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CHAPTER I 
INTRODUCTION 
CHAPTER I 
INTRODUCTION 
A. HISTORY OF LEAD POISONING 
Lead and its compounds have been used by man for at least six 
thousand years (Brunton, 1937). It was among the first metals known to the 
early Hebrews, Egyptians, and Phoenicians and the symptoms of plumbism 
were familiar to Greek, Roman, and Arabian physicians before the Christian 
Era. Hippocrates in 370 B. C. was the first to recognize lead's toxic prop-
erties and Nicander in the second century B. C. observed the relationship 
of constipation, abdominal pain, and pallor to the action of lead on the body. 
Over the years more has been written about the causation and symptomatol-
ogy of poisoning by lead than by any other toxic agent (Johnstone,. 1966). 
Modern interest in lead poisoning dates from the 17th and 18th centuries 
when outbreaks of lead poisoning occurred throughout western Europe as a 
result of the addition of lead to wine. to promote fermentation and because of 
its use in the manufacture and storage of cider and in material for cooking-
· vessels and other household articles (Cantarow and Trumper, 1944). Crato 
in about 1600 attributed the colic which was common in Moravia to the use 
of "falsified wine" and Citosis, a physician of Poitiers, in 1616 mentioned 
bad wine which had been treated with lead as the cause of colic. In 1745 
Huxham dE;?scribed a disease appearing in Devonshire, England having 
I 
--
--
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symptoms identical with true lead colic and this was traced by Sir George 
Baker (1767) to the lead used in the manufacture and storage of cider. A 
similar type of colic of similar etiology occurred in Spain and was described 
by Luzuriaga in 1796. 
Tanquerel des Planches in 1839 published an epoch-making treatise 
containing an accurate clinical description of lead poisoning and since Tan-
querel' s time, little has been added to our clinic_al knowledge of lead poison-
ing. This treatise was responsible for the initiation of a period of intensive 
clinical and experimental investigation of lead poisoning and this research 
is pr:esently continuing. 
GilfiHa~ (1965) has recently linked lead poisoning with the fal.1 of the 
Roman Empire. The Roman upper class died out with great rapidity begin-
ning about the 2nd or 1st century B. C. and plumbism is believed to have 
contributed to this decimation because the upper class commonly used lead-
lined pots, lead aqueducts, and lead containing paints, cosmetics, and home 
prepared concoctions such as wine-mead. The poorer classes could not 
afford the luxury of using lead and were therefore spared lead's toxic effects. 
B. ABSORPTION OF LEAD 
1. Respiratory Tract 
Emissions of lead into the atmosphere result from burning of lead-
bearing materials, industrial processes in which lead is used, re-entrain-
3 
ment of lead-beari.ng soil, and combustion of lead-bearing fuels. Gasoline 
and coal are the two major lead-bearing fuels and coal combustion in the 
Cincinnati area emits between 54 and 270 pounds of lead into the atmosphere 
each day. depending on the amount of lead retained in the ash or air 
cleaning equipment. Combu.stidri of leaded-gasoline in the Cincinnati area 
causes an emission of 1700 pounds of lead into the atmosphere per day 
(McCaldin, 1966). 
The atmospheric lead concentration of a general urban area ranges 
from 1 to 3 p.g/m3• while measurements taken near automobile traffic 
increase to 40 ;ig/m3 (U.S. D. H. E.W., 1965). This indicates the importanci 
of combustion of leaded-gasoline as a source of atmospheric lead pollution. 
Kehoe (1964a) has calculated that the respiratory intake of lead by a 
normal adult living in a large city is in the order of 30 to 40 ,ug per day. 
Of this amount, 70 to 75% is discharged in the expired air and only 25 to 30%, 
never more than 50%. is retained in the lungs a.nd absorbed.· The respira-
tory tract thus can account for an absorption of up to 20 _.ug of lead each day. 
A number of factors influence the absorption of lead by the respiratory 
tract. Among these are particle size and density,· r·ate and depth of breath-
ing, duration of exposure to the lead~ and the hygroscopic nature of the lead 
particle (Tomashefski and Mitchell, 1966). The early studies of Goadby and 
Goodbody (1909) and of Blumgart (1923-24) have shown that even relatively 
4 
insoluble lead compounds can be absorbed by the respiratory tract from the 
nasopharynx to the pulmonary alveoli. Robinson et al. (cited by Tomashef-
ski and Mitchell, 1966) have found that the particle size of atmospheric 
lead in the Los Angeles area is of such a magnitude that it reaches the 
alveoli where deposition, retention, and absorption via the lungs can occur. 
A total of 60% of the atmospheric lead particles were found to have a 
diameter less than 0. 45 micron, ·75% less than O. 90 micron, and 90% less 
than 1. 60 microns. 
2. Gastrointestinal Tract 
Lead is present in all classes of natural foods and water and the 
average daily intake from the diet is about 0. 3 mg pe.r day with a range 
between 0.1 and 2. 0 mg (Kehoe, 1961). Only 10% of the ingested lead is· 
absorbed (Kehoe, 1961) and this absorption occurs mainly from the small 
intestine, to a lesser extent .from the colon, and not at all from the stomach 
(Harvey, 1965). The major part of the absorbed lead enters the entero-
hepatic circulation and only a small portion ever reaches the systemic 
circulation (Cantarow and Trumper, 1944). Thus, even though 90% of the 
total lead intake is contributed by the diet, the respiratory tract, under 
normal conditions, is the most important portal of entry of lead. 
Kehoe et al. (1943) have shown that none of the variations in milk, cal-
cium, phosphorus, pectin, or ascorbic acid intake affect the absorption of 
lead. The only factor found to significantly influence this absorption was 
~ 
--
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the motor activity of the bowel. A decrease in the number of evacuations 
caused an increased absorption of lead, while an increase in frequency 
caused a decreased absorption. 
3. Skin 
Absorption of inorganic lead compounds through the intact skin is of 
little significance -in the development of lead poisoning (Legge and Goadby, 
1912; Hamilton, 1912; Oliver, 1914): H.owever, lead salts can be absorbed. 
through abrasions and numerous cases of lead poisoning have heen reported 
to occur following the application of lead containing lotions_ and ointments to . 
ulcers, burns,· ·skin ·eruptions, and areas -of inflammation (Tanquerel des 
Planches, 1839). Plumbism has also been reported to occur from the ab-
sorption of lead from bullets lodged in tissues (Oliver; 1914; Machle, 1940). 
Organic lead compounds such as tetraethyl lead (TEL) have been 
shown to pass readily through intact skin. Kehoe _and Tham~nn in 1931 
demonstrated that pure TEL is rapidly absorbed when applied to the skin 
of rabbits. However, TEL absorption from gasoline containing 0.1% TEL 
was found to be inappreciable. Since TEL-is eventually converted in the 
body to inorganic lead, continued absorption of small amounts of TEL · 
can result in the classical syndrome of chroniclead intoxication .. 
C. TRANSPORTATION OF LEAD IN THE BODY 
r.~· ---------------~ 
---
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Once lead is absorbed, it is transported by the blood in which 90 to 
95% is bound to the red blood cells (Blumberg and Scott, 1935; Cantarow 
and Trumper, 1944; Stover, 1959). The form in which it is carried is 
believed to be either as an albuminate (Oliver, 1914), a dibasic phosphate in 
colloidal form (Aub et al. 1925), or a diphosphoglycerate (Maxwell and 
Bischoff, 1929). Witsc:bi (1965) has recently found that lead is bound at least 
partly to the deeper layers of the plasma protein film on the erythrocytic 
surface. 
The normal range of lead levels in blood is 15 to 40 pg per 100 ml 
(Goldwater and Hoover, 1967) with the upper limit of normal being 60 to 80 
pg per 100 ml. Kehoe (1964b} stated that when the lead concentration in the 
blood reaches or exceeds the level of 80 pg per 100 g, the individual has 
absorbed a potentially-dangerous quantity of lead. Several investigators, 
however, believe that a blood lead level of only 60 pg per 100 ml is 
indicative of an excessive lead absorption (Berman, 1966; Cramer et al., 
1966; Weber, 1966}. 
D. DEPOSITION OF LEAD IN THE BODY 
Lead present in the general circulation is at first distributed to the 
kidneys, liver,. lungs, spleen, and muscle. However, within a few days, 
the lead is re-distributed to the bones where it is deposited as an insoluble 
tertiary lead phosphate (Aub et al., 1925). Normal individuals have a 
~--------------------~ 
-
7 
higher concentration of lead in the long bones than in the flat bones, how-
ever, in cases of lead poisoning the reverse has been found to be true 
(Kehoe, 1961). Growing bones have the highest concentration of lead in 
the epiphyseal portion of the long bones and "lead deposits may be detected 
·• 
·by X-ray examination as rings of increased density in the ossification. 
centers of the epiphyseal cartilage and as a series of transverse lines in 
the diaphyses" (Harvey, 1965}. These findings are of diagnostic importance 
in the determination of lead poisoning in children. 
Bolanowski et al. (1964) using adult male albino rats injected with a 
single dose of Pb210 divided the organs into three basic compartments 
differing in lead exchange rates. The first is the rapid exchange pool 
consisting of blood, heart, lungs, liver, kidneys, spleen, and GI tract. 
The second compartment is the intermediate pool consisting of the muscles 
and skin and the third is the slow exchange pool including bone and 
whole tail. 
Factors affecting the metabolism of calcium similarly affect the 
metabolism of lead (Harvey, 1965). "High phosphate intake favors 
. . 
skeletal storage of lead. and a lowering of the lead content in soft tissues. 11 
A high calcium intake in the absence of an elevated phosphate intake 
,.,.-
----------------------------------------------, 
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causes a mobilization of lead from the bone due to competition with lead 
for the available phosphate. "Vitamin D tends to promote the deposition 
of lead in bone provided a sufficient amount of phosphate is available. 
parathyroid hormone mobilizes lead from the skeleton and elevates the 
blood level and urinary excretion. " Acidosis promotes the mobilization of 
• 
lead-from bone as do iodides and bicarbonate. 
The body of an average 80 kg human has been reported to contain 
100 to 400 mg of lead (Kehoe, 1961). The concentration of lead found in the 
brain, lung, heart, liver, spleen, kidney, muscle, flat bone, and long 
bone expressed as mean lead mg per 100 g of tissue is 0. 04, c(.cfa, O. 04, 
0.12, 0. 03, 0. 05, 0. 03, 0. 65, and 1. 78, res-pectively. 
E. EXCRETION OF LEAD 
The total intake of lead due to food, beverages, and air approximates 
O. 33 mg per day (Kehoe, 1964a). Of this amount, 0. 3 mg per day is 
eliminated in the feces and 0. 03 mg per day is eliminated in the urine. 
The amount present" in the feces consists largely of the lead that had 
passed through the GI tract without being absorbed, while the amount 
in the urine reflects that amount that was absorbed and is present in the 
blood. The normal individual has a urinary lead content of 20 to 65 )lg 
-
,,.-
--------------------------------------------------------, 
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per liter with an average of 35 (Goldwater and Hoover, 1967). The upper 
limit of normal has been stated to be 150 pg of lead per liter of urine 
(Kehoe, 1964b). 
F. LEAD INTOXICATION 
The accumulation of large amounts of body lead constitutes an 
important health hazard with regard to both children and adults. Lead 
poisoning in children is often the result of oral ingestion of chips of lead-
containing paint, while lead poisoning in adults usually results from 
accidental exposure to lead in an industrial environment. 
1. Signs and Symptoms 
a. A cute lead intoxication 
"Acute lead poisoning is quite rare and occurs following the 
accidental ingestion of lead compounds that dissolve readily in the stomach 
contents" (Harvey, 1965). The symptoms are a sweet metallic taste, 
thirst, nausea, vomiting, abdominal pain, and diarrhea or constipation. 
A cute nervous system symptoms including parasthesias, pain and 
muscle weakness occur and kidney damage and urinary changes are evident. 
The shock syndrome may develop and acute hemolytic anemia may be 
present. Death usually results within 1 to 2 days. 
I 
p·_·····----------------------------1 
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b. Chronic lead intoxication 
The major clinical features of adult lead intoxication are abdominal 
pain, constipation, vomiting, nonabdominal pain, muscle weakness, 
and parasthesia (Dagg et al., 1965). Abdominal pain is the most prevalent 
complaint and in Dagg's study occurred in 90% of the patients with lead 
poisoning. Anemia, stippled erythrocytes, l~ad line on the gums, and 
reticulocytosis are also commonly seen in lead-intoxicated patients. 
Anemia was noted in over 90% of the patients~ while stippled red cells 
were present in 76%. 
In children, the microcytic hypochromic anemia associated with 
chronic lead intoxication is often more pronounced than that seen in 
adults and i$ oftep ac~ompanied with abnormallylow serum i~on leve~s 
(Watson et al., 195~U. Often, the pallor due to anemia is the only sign 
or symptom seen in children with- chronic lead poisoning ... As in adults, 
children demonstrate GI disturbances, anorexia, vomiting, and 
constipation. Children, however, usually develop more severe central 
nerv~us system complica~ions including encephilitis and mental retardation .. 
Chisolm Jr. (196!5) has stated that the sericms sequelae of lead intoxication 
during early childhood are mental retardation, behavior disturbances, 
--
11 
convulsive disorders, and nephropathy. 
i. Stippled erythrocytes 
Behrend in 1899 was the first to report that lead causes stippling of 
the erythrocyte. 'Today, we recognize that two different types of gran-
ulations may be present in the erythrocytes of lead-intoxicated patients 
and -animals (-Griggs, 1964). The first type of granulation is due to an 
accumulation of excessive iron urn.:1.sable for hemoglobin formation and 
the second type represents damaged mitochondria that do not contain 
iron. 
The spleen is thought to play an important role in regulating the 
number of stippled erythrocytes in the general circulation. Stippled 
erythrocytes are young cells (Baikie and Valtis, 1954) and Bessis and 
Breton-Gorius (1962) have suggested that the spleen removes these cells 
from the circulation and causes removal of the granules either by maturing 
the cell through some unknown mechanism or by a process similar 
to that seen for the removal of siderocytic granules from red blood 
cells. 
ii. Erythrocytic fragility 
The erythrocytes from patients with lead poisoning often demonstrate 
increased resistance to osmotic lysis and increased susceptibility to 
pr:_· ----------------------------. 
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mechanical trauma (Griggs, 1964). Aub et al. (1925) produced similar 
effects in vitro by incubating normal red blood cells with lead. Harris 
and Greenberg (1954) also demonstrated that the addition of lead chloride 
to normal human red blood cells suspended in autologous serum or 
isotonic saline is followed by an increase in the mechanical fragility of 
the cells and a decrease in susceptibility to osmotic lysis. Waldron (1964), 
however, found that red blood cells incubated with lead have only a 
slightly greater mechanical fragility index than controls. 
Changes in osmotic and mechanical fragility indicate alterations in 
the morphology and permeability of the erythrocytic membrane. Min 
(1964) has reported that lead chloride induced a loss of potassium from 
rabbit erythrocytes and Hasan et al. (1967a) have found that the erythro-
cytes from lead-exposed workers have an enhanced potassium loss. The 
activity of the /Na+ +K+ I -ATPase present in the membranes of the red 
blood cells from lead-exposed individuals has been reported to be 
decreased (Hasan et al., 1967b) and this finding is consistent with an 
accelerated loss of intracellular potassium since /Na+ +K+ I -ATPase is 
closely associated with active ion transport. 
The red blood cell's increased resistance to osmotic lysis seen in 
both the in vivo and in vitro experiments indicates that a greater amount 
--
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of water could enter the cell before lysis occurs. The decrease in mean 
corpuscular volume, the increase in specific gravity, and the increase in 
mean corpuscular hemoglobin concentration indicate that "leaded" cells 
are shrunken and therefore have a greater capacity for swelling in hypotonic 
solutions. 
iii. Erythrocyte survival 
Hernberg {1967) has reported that workers exposed to lead for a 
mean of six years have a 20% shorter red cell survival time than non-
exposed workers and this difference was found to be highly significant. 
Sheets et al. {1951), using the Ashby technique, studied the red cell 
survival time from a patient with lead poisoning and found that 50% of 
the cells had d_isappeared in approximately 25 days, compared to a normal 
50% survival time of 55 to 60 days. Rubino et al. (1958), Crepet et al. 
(1963), and Griggs {1964) have also reported shortened red blood cell 
survival times in lead-poisoned adults. Leikin and Eng (1963) have likewise 
shown that children with chronic lead poisoning have shortened red cell 
survival times. Those children having a relatively short history of 
lead intoxication demonstrated the most pronounced shortening. 
iv. Anemia 
The precise cause of lead induced anemia is not known at present. 
Aub et al. {1925) concluded that the anemia was hemolytic and this view was 
~ 
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supported by the work of McFadzean and Davis (1949) and by Pirrie (1952). 
These latter two groups of investigators demonstrated that the anemia 
which developed in lead-poisoned animals was rapid in onset and was re-
lieved by splenectomy. More recently Crepet et al. (1963) have reported 
that the anemia is produced by hyperhemolysis and by defective hemoglobin 
formation and these factors may act together or individually. Waldron (1966) 
also stated that the anemia of lead· poisoning is due to the effect of lead on the 
enzymes responsible for heme synthesis . Gajdos et al. (1964) defined the 
anemia induced in experimental lead poisoning as being due to (1) inhibition 
of heme synthetase, the enzyme that catalyses incorporation of iron into 
protoporphyrin, (2) inhibition of erythropoiesis, and (3) partial hemols:sis of 
the red blood cells which shortens their survival time. Inhibition of heme 
synthetase by lead has also been reported by deBruin and Hoolboom (1967). 
v. Encephalopathy in children 
The infantile brain is extremely susceptible to the toxic effects of lea 
and it is common for lead-poisoned children to develop restlessness, 
irritability, and convulsions. Once encephalopathy occurs, there is a case 
fatality rate of almost 25% with more than 50% of the survivors having 
damage to the central nervous system (Smith et al., 1965). 
Okazaki et al. (1963) using the brains from lead-poisoned children 
found that the hippocampal and frontal cortices contained the highest lead 
~-"-------------~----------------~-,· 
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levels, while the occipital white matter and pons had the lowest levels. 
These investigators suggested that the initial effects of lead poisoning were 
selectively exerted upon the small caliber blood vessels in the brain 
causing increased permeability, focal necrosis; occlusion, and the transu-
dation of plasma fluid into the perivascular, interstitial and subpial spaces. 
Pentschew (1965) reported that the brains from lead-poisoned children 
had dilated capillaries with swollen endothelial nuclei protruding into the 
lumen and microglial nodules spreading out over various gray areas and 
also over the white matter. The molecular layer of the cerebellar cortex 
contained loose accumulations of microglia cells and this layer was found 
to suffer the greatest damage in lead encephalopathy. The underlying 
cause of lead encephalopathy was considered to be a toxic disorder of 
porphyrin synthesis which resulted in a chronic metabolic hypoxidosis. 
vi. Effect of lead on the germ cells 
Constantin Paul in 1860 was the first to allege that lead might injure 
the male germ cell. Based upon his observations of clinical cases, he 
reported that lead poisoning of either the mother or father often caused 
stillbirth and that the infant mortality of children born of such parents was 
particularly high during the first three years of life. 
Meillere (1903), Baader (1928), and Fraenkel (1905) have shown that 
lead-exposed workers have dimini.shed sperm motility, testicular atrophy. and 
~-------------------------------. 
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diminished spermatogenesis. Koinuma (1926) compared the marital life 
records of workers exposed to lead in Japanese storage battery plants with 
the histories of those working in nonlead occupations and reported that 
infertile marriages constituted 24. 7% for the lead group as opposed to only 
14. 8% for the nonlead group. The percentage of pregnancies ending pre-
maturely or in stillbirth was 8. 2% for the lead and O. 2% _for the control group 
Additional evidence that lead can inj.ure the male germ cell was supplied 
by Weller (1915-16, 1916-17) when he demonstrated that the offspring of 
lead-poisoned male guinea pigs were underweight and weak. The "leaded" 
males were usually not sterile, but when.mated with a normal female the 
weight of their young was_ 18. 5% below normal. Similar results have also 
been reported using rabbits and fowl (Col.e and Bachuber, 1914). Puhac et al. 
(1963) fed male rats lead nitrate for 30 days and found that when they were 
paired with untreated females no reproduction took place for 45 days. 
In women lead is an active abortifacient and an increased frequency of 
miscarriages, stillbirths, and premature births in female lead workers has 
been recognized for years. Lead-exposed women may experience transi-
tory periods of sterility with subsequent occurrence of normal pregnancy 
after withdrawl from exposure and this indicates that lead injures only the 
germ cells formed during the period of intoxication and that the damage to 
the gonads is not permanent (Paul, 1860). Women who have had several 
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miscarriages and stillbirths during periods of lead exposure may sub-
sequently have normal pregnancy after cessation of exposure. If living 
children are born to women with lead intoxication, they usually are smaller. 
weaker. slower in development. and have a higher infant mortality (Legge 
and Goodbody, 1912; Aub et al., 1925) and similar observations have been 
made in dogs, cats, rabbits, guinea pigs, and fowl. These phenomena have 
been attributed to (a) placental injury and hemorrhage, (b) degenerative 
changes in the chorionic epithelium, (c) spasm of the uterine muscl~. and 
(d) direct action of lead on the fetal tissue (Cantarow and Trumper, 1944). 
Lead-poisoned female rabbits have shown alterations of the chorion 
resulting in the death of the embryo and Hamilton (Cited by Moeschlin, 1965) 
reported that women abort due to lesions of the chorion epithelium or of the 
fetus itself. Bell (1924) from his studies on the action of lead on malignant 
cells concluded that lead acts directly on the embryonic cells of the chorion 
·epithelium causing degeneration. Since lead passes from the maternal 
circulation to the fetus and has been found in all.of the fetal organs 
(Cantarow and Trµmper, 1944); it is also possible to speculate that intra-
uterine death and abortion are caused by the direct toxic action of lead on 
fetal tissues. Bell (1924) found that lead inhibits the growth of embryonal 
and other growing tissues and concluded that the arrest of growth in animal 
organisms is strictly proportional to the capacity for, or power of, growth. 
---
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The fact that children born of mothers with lead poisoning develop more 
slowly than normal and have a higher mortality during the first year of 
life indicates that intrauterine exposure to lead has damaging effects. 
vii. Lead nephropathy 
Damage of the kidney has long been associated with lead poisoning 
and the nature of damage depends upon the type of intoxication {Albahary 
et al., 1965). Tubular involveme·nt is dominant in the acute form, while 
- - .' .. · --- .. 
diffuse changes occur after prolonged exposure. In chronic lead poisoning, 
nephrosclerosis develops as a result of damage" to the" renal vessels. 
- -. - .- . -- - . .. 
Oliguria, albuminuria, and cylinduria have been reported to occur in 
lead:-exposed workers (Legge and Goadby, 1912; Oliver, 1914). Dreessen et 
al.- (1941) found that albuminuria 0ccurs twice as frequently in lead-exposed 
workers with other evidence of lead intoxication as in nonaffected workers" 
-· . --
or in workers in other industries, the incidence and severity of albuminuria 
increasing with duration of exposure and increasing· concentrations of lead i 
- -
the air to which the subjects were exposed. Following the intravenous in-
Jection of collo~dal lead preparations to_ human subject_s, Bell et al. (1925) 
observed oliguria, albuminuria, and edema, with marked degenerative 
. changes in the renal tubular epitheiium: Cases of lead intoxicatfori have also 
been reported with glycosuria, aminoaciduria (Wilson et al., 1953) and hyper 
phosphaturia (Chisolm Jr~ et al., 1955; Chisolm Jr. and Leahy, 1962). 
~ 
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The renal tubular cell linings of rats fed a 1 % lead acetate diet were 
found to contain intranuclear inclusions after eight weeks on the diet, cyto-
plasmic vacuoles after one week, and swollen mitochondria with disrupted 
cristae after three weeks (Goyer et al., 1965). Galle and Morel-Maroger 
(1965) reported that in both man and rats lead selectively affects the proxi-
mal tubular cells and produces intranuclear inclusions,. iron containing 
intracytoplasmic inclusions, and marked mitochondrial lesions. Intranuclear 
acidophilic inclusion bodies were also found by Blackman (1936} in the renal 
tubular epithelium of 21 children with lead encephalopathy. Some of the af-
fected cells were enlarged, others flattened and basophiHc in app.earance, 
some contained fat and some were necrotic. Some of the tubules were atro-
phied and there was also evidence of mild chronic inflammation and fibrosis. 
Henderson (1954) has reported follow up studies on children in Qu.eens ... 
land, Australia who had acquired lead poisoning from the ingestion of 
powdered white lead paint. He noted that many of these children died later 
in life due to chronic nephritis, ahd of the 127 who could be located alive, 
17 had hypertension and albuminuria. Studies by Croll (1929), Nye (1933), 
and Murray (1939) have shown that chronic renal disease was unusually 
frequent in persons under forty years of age in Queensland. This high 
incidence was related to the occurrence of lead poisoning in infancy and 
early childhood due to the ingestion of paint from the veranda railings of the 
homes. Nye has concluded that every child who has had lead poisoning is a 
.·.·. 
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potential subject for chronic renal disease later in life. 
2. Heme Biosynthesis 
a. Normal heme biosynthesis 
The biosynthetic sequence of heme has been elucidated as a result of 
the research conducted mainly in the laboratories of Shemin and Granick in 
the United States and Neuberger and Rimington in Great Britain. As early 
, as 1948 it was found that avian red blood cells can synthesize heme in vitro 
(Shemin et al., 1948) and soon after, cell free extracts of duck erythrocytes 
were found to accomplish heme synthesis from the proper substrates (She-
min et al., 1955). When chicken cells, rabbit reticulocytes, or human red 
cells from er-ythroblastosis fetalis are hemolyzed,. a number of the enzymes 
of the heme biosynthetic pathway are found to be soluble and can be separated 
from each other by zone electrophoresis on starch (Granick and Mauzerall, 
1958). These soluble enzymes are localized in the cytoplasm and include 
delta-aminolevulinic acid (ALA) dehydrase, porphobilinogen (PBG) deamin-
ase, uroporphyrinogen (UPG) isomerase, and uroporphyrinogen decarboxy-
lase. The insoluble enzymes are localized in the mitochondria and include 
ALA synthetase, coproporphyrinogen (CPG) oxidase, and heme synthetase 
(Sano and Granick, 1961). 
The first step in heme synthesis is tl:c condensation of succinyl CoA 
with glycine (Shemin et al., 1955; Gibson et al., 1958; Kikuchi et al., 1958) 
to form o<. -amino-8-keto adipic acid which readily decarboxylates yielding 
delta-aminolevulinic acid (Shemin et al.,' 1955; Neuberger, 1961). This 
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reaction is catalyzed by the enzyme ALA synthetase and requires pyridoxal 
phosphate as a co-factor (Lascelles, 1957; Schulman and Richert, 1957; 
Kikuchi et al., 1958). The enzyme ALA dehydrase condenses two molecules 
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of ALA forming one molecule of porphobilinogen and water (Gibson et al., 
1955). Three molecules of porphobilinogen then combine under the influence 
of PBG deaminase to form tripyrryl methane and this in the presence of 
UPG isomerase and PBG is converted to uroporphyrinogen III (Bogorad, · 
1958a, b; Cornford, 1964). The four acetic acid side chains of uroporphyrin-
ogen III are then decarboxylated by UPG decarboxylase to produce copropor-
phyrinogen III (Mauzerall and Granick, 1958). Two propionic acid side 
chains of coproporphyrinogen III are oxidatively decarboxylated to form vinyl 
groups by CPG oxidase and this results in the formation of protoporphyrino-
gen IX (Sano and Granick, 19 61). .. Protoporphyrinogen IX is then autooxidized 
to form protoporphyrin IX (Sano and Granick, 1961) and heme synthetase 
inserts one ferrous ion into each molecule of protoporphyrin IX forming 
heme (Goldberg et al., 1956; Labbe and Hubbard, 1960). 
Shemin (1957) demonstrated that labelled glycine, when fed to humans, 
was incorporated into the heme of newly formed erythrocytes and this led 
to the finding that glycine and succinyl CoA are the elementary building 
blocks of heme. Most of the succinyl CoA required for condensation with 
glycine originates from the oxidation of ...(-ketoglutarate through the 
operation of the tricarboxylic acid cycle, ::i.lthough some is generated from 
succinate and CoA in the presence of a nucleoside triphosphate by the enzyme 
.succinyl CoA synthetase (Brown, 1958; Shemin and Kumin, 1952). The 
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mitochondria seem to be the principal site of ALA synthesis because 
succinyl CoA is formed via oL.. -ketoglutarate oxidase which is a mito-
chondrial enzyme complex and because ALA synthetase is present in 
mitochondria. As the mitochondria degenerate in maturing red blood 
cells, the ability to synthesize ALA decreases and in mature erythrocytes 
only the enzyme a.ctivitie~ that convert ALA to coproporphyrinogen can 
be detected (Granick and Levere, 1964). 
b. Effect of lead on heme synthesis 
Lead has been found to exert an inhibitory effect on several of the 
enzymes necessary for heme synthesis e.g. ALA dehydrase,. CPG 
oxidase, and heme synthetase. ALA dehydrase (Gibson et al., 1955) 
and heme synthetase (Schwartz et al., 1959) both contain essential 
sulfhydryl groups and a blockage of such groups by lead may be the cause 
of the inhibition of their activity. 
i. A LA dehydrase 
Several authors have reported that the activity of this enzyme is 
decreased in erythrocytes from lead-intoxicated patients (Lichtman and 
Feldman, 1963; Bonsignore, 1966; deBruin and Hoolboom, 1967). Bonsignor 
et al., (1965a) injected rabbits subcutaneously with lead acetate and found 
that the activity of A LA dehydrase in the blood was decreased 1 hour after 
injection. The activity returned to normal between the first and sixth day 
. 24 
after injection, hut then decreased again and remained low to the twentieth 
day when further observations were discontinued. In man, A LA dehydrase 
has been found to remain inhibited for up to three years after cessation of 
lead exposure (Saita and Moreo, 1964). 
Bons_ignore et al. (1965b) have found that the inhibitiorl: of the enzyme 
A LA dehydrase is competitive and can partially be removed by administer-
ing sulfhydryl compounds as cysteine and glutathione. By using in vitro 
techniques, a maximum reactivation of 60% of the ALA dehydrase inhibited 
by a solution of 10- 5M lead acetate was produced by cysteine in a concentra-
tion of 2. 5 x 10-2M. 
- ii. CPG oxidase 
An increased urinary excretion of coproporphyrin from individuals 
with lead intoxication has been known for years. Coproporphyrinogen III is 
the compound that is excreted in the urine, however, it is rapidly oxidized 
to coproporphyrin III (Watson et al. , 1951; Weatherall, 1952). The increased 
urinary excretion of coproporphyrin III in lead poisoning has been postulated 
to be due to destruction in the bone marrow of young red blood cells con-
taining large amounts of coproporphyrinogen III (Schmid et al., 1950). This 
increased amount of coproporphyrinogen III in the young red blood cells is a 
result of the inhibition of the enzyme CPG oxidase by lead. 
iii. Heme synthetase 
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Erythrocyte protoporphyrin IX levels have been found by Rubino et al. 
(1958) to be elevated in 21 of 22 patients with lead poisoning. Increased 
amounts of protoporphyrin IX in the erythrocytes of lead poisoned patients 
have also been found by Vigliani and Waldenstrom (1937). Whitaker ~nd 
Vietti (1958) have shown that children with lead intoxication also have 
increased amounts of protoporphyrin IX in the erythrocytes. Lead inhibits 
the in vitro synthesis of heme from protoporphyrin IX and iron of chicken, 
rabbit, and human erythrocytes (Rimington, 1951; Jandl et al., 1959) and it 
has been reported that in humans, elevated levels of protoporphyrin IX 
persist in the erythrocytes up to nine years after cessation of lead exposure 
(Saita and Moreo, 1964). 
3. Treatment 
a. A cute lead poisoning 
Gastric lav'age with a 3% sodium sulfate solution combined with ample 
amounts of animal charcoal should be administered immediately. This 
converts the soluble lead into the slightly soluble lead sulfate and causes 
adsorption of the lead to the charcoal. Magnesium sulfate can be given as 
a cathartic in order to rush the ingested lead through the intestinal tract 
with as little absorption as possible. Calcium disodiurn edetate (CaNa2 
EDTA) is then administered. 
b. Chronic lead poisoning 
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i. Specific therapy 
Dimercaprol (2, 3-dimercaptopropanol) has been reported to be 
effective in the treatment of chronic lead poisoning (Ryder and Kehoe, 1947; 
Harvey, 1965; Moeschlin, 1965). Even though it initially causes an 
increased urinary excretion of lead, this effect is temporary and the amount 
of lead actually mobilized is negligible. It appears that dimercaprol is only 
able to chelate the lead in blood and that "lead in bone and soft tissue is too 
firmly boun« to be mobilized. " 
Calcium disodium edetate, an ion exchanger, was discovered in 1953 
to be effective in the treatment of lead intoxication (Rubin et al., 1953) and 
is now the drug of choice. Lead displaces calcium from the calcium 
disodium edetate and forms a water-soluble lead chelate which is eliminated 
by the kidneys. Several investigators havE:: reported that lead excretion 
increases up to ten fold after initiation of calcium disodium edetate therapy 
(Hernberg and Laamanen, 1964; Westerman et al., 1965; Selander, 1967). 
The use of calcium disodium edetate, however, has certain disad-
vantages among which are its nephrotoxicity (Foreman .et al., 1956; Vogt 
and Cottier, 1957); and the necessity of it being administered intravenously 
to obtain maximal efficiency. Opinions on the efficacy of oral calcium di-
sodium edetate vary. Some authors maintain that it is effective (Manville 
and Moser, 1955; Bell et al., 1956), whereas others consider oral administration 
to be contraindicated because it increases the absorption of lead from the gut and 
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may precipitate or increase the symptoms of poisoning (Kehoe, 1955; Byers, 
1959). Selander (1967) reported that oral calcium disodium edetate was not 
effectiye in causing an increased lead excretion and stated that this was due 
to its poor absorption from the gastrointestinal tract. 
Penicillamine administered orally has been shown to be effective in 
the treatment of lead poisoning (Boulding and Baker, 19S.7; Ohlsson, 1962; 
Selander et al., 1966). Calcium disoqium edetate is preferable in the 
treatment of severe cases of lead intoxication due to its ability to mobilize 
2 to 8 ~imes more urinary lead than penicillamine (Gaultier et al., 1966). 
However, penicillamine's use in the treatment of lead intoxication is assure 
because of its effectiveness when given orally and its less severe side effect 
Penicillamine has also been recommended as a prophylactic agent against 
lead poisoning (Albahary and Guillaume; 1966). 
ii. Spasmolytics 
Chlorpromazine, papaverine, extract of belladonna, and calcium 
gluconate are the most effective drugs for the treatment of lead colic 
(Moeschlin, 1965). Hot compresses and hot baths may also help relieve 
the cramps associated with the colic. 
iii. Sedatives 
Chlorpromazine and various forms of barbiturates are used for the 
treatment of excitement, mania, and convulsions. Pentothal-sodium 
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administered intravenously is used for the treatment of lead encephalopathy. 
iv. Puriatives 
Kehoe (1943) has found that the motor activity of the bowel influences 
the absorption of lead. A decrease in the number of evacuations causes an 
increased absorption of lead, while an increase in the frequency causes a 
decreased absorption. Sodium sulfate is the drug of choice for causing 
regular evacuation of the bowel (Moeschlin, 1965). 
4. Laboratory Tests Used for the Early Detection of 
Increased Lead Exposure 
a. Number of basophilic stippled cells in peripheral blood 
As mentioned previously, there usually is an increased number of 
stippled erythrocytes in the peripheral blood of lead-exposed individuals. 
Stippling, however, is generally considered an unreliable criterion of lead 
intoxication because it also occurs in a large number of blood diseases such 
as various types of hemolytic anemia, post hemorrhagic anemia, leukemia, 
and after exposure to benzene, aniline, carbon monoxide, arsenic, copper, 
and bismuth (Haeger-Aronsen, 1960). The upper limit of normal is approxi-
mate and the values cited vary considerably, ranging from 1 per 10, 000 RBC 
(Schmidt, 1919} to 90 per 10, 000 (Sanders, 1943). 
b. Determination of coproporphyrin III in the urine 
~----------~---------, 
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Coproporphyrin III excretion in the urine has been shown to be elevated 
in lead poisoning (Wyllie, 1955; Holecek, 1957; Benson and Chisolm. 1960; 
Haeger-Aronsen, 1960). However, coproporphyrin levels are also increased 
in various forms of anemia, particularly hemolytic anemias. in jaundice 
whether due to diffuse liver damage or to biliary obstruction. in some 
infectious diseases such as pneumonia and acute poliomyelitis, and in 
several types of intoxication including mercury. bismuth. sulfon~l. and 
sulfonamide poisoning (Haeger-Arons en. 1960). The upper limit' of :normal 
for urinary coproporphyrin is 15 pg per 100 ml of urine~ 
c. Determination of the concentration of.lead in hair 
Kopito et al. (1967) have recently described a procedure for the analysi 
of lead in hair. This procedu~e involves first segmenting the hair, then 
washing each segment. and finally digesting the. washed segments in nitric 
and perchloric acids. The lead concentration of each segment is then 
obtained by use of an atomic absorption spectrophotometer. 
Using the procedure described above. Kopito et al. have shown that 
patients with recent lead ingestion have a high lead concentration in hair 
near the scalp, while patients with chronic lead ingestion have elevated 
lead concentrations in all hair segments. The lead levels in hair were 
reported to have a good correlation with the radiographic findings of 
increased bone density and with other laboratory findings. 
~·------------------------1 
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'I'he laboratory procedures used for determining the concentration of 
lead in hair, however, are time consuming and require skilled laboratory 
assistants. Therefore, the practicality of using lead in hair as a screening 
test for early detection of increased lead absorption is questionable. This 
procedure is also not suitable for diagnosing acute cases of lead intoxication 
Still another limitation for the use of this method is the fact that the hair of 
Negro children grows at a very slow rate and this makes it extremely 
difficult to separate their hair into enough segments· for the performance of 
a proper lead analysis. 
d. . Determination of lead in blood and urine 
Most investigators. agree that an increased level of lead in .the blood. 
and urine is the most specific sign of increased lead absorbance. It m.u$t 
be remembered, however, that the blood is rapidly cle~red of lead and 
blood lead levels are considered of value only in acute cases of lead intoxi-
cation. Berman {1966) has reported that the blood lead levels in chronic 
cases of lead poisoning are not remarkable. 
'!'he drawing of blood samples and the analytical procedures for 
determining the lead levels in blood and urine are time consuming processes 
requiring skilled per-sonnel and it therefore appears that the determination 
of lead in the blood and urine is not practical as a screening test for early 
detection of increased lead absorption. 
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e. Determination of delta-aminolevulinic acid (ALA) in 
the urine 
Mauzerall and Granick in 1956 developed a sensitive colorimetric 
method for the quantitative determination of urinary ALA. Using this 
method, a 1. 0 ml aliquot of urine (pH 5 to 7) containing porphobilinogen, 
urea, and A LA is placed on a column of Dowex 2 resin in the acetate form. 
The column is washed with two 2 ml portions of water and porphobilinogen 
is retained on the Dow ex 2 column, while urea and A LA are washed off. 
The washings from the first column are then passed through a column of 
Dowex 50 resin in the acid form. This Dowex 50 column containing ALA 
and urea is then washed with 16 ml of water to remove the urea. A 3 ml 
aliquot of 0. 5 M sodium acetate is added to the column and after draining, 
the ALA is eluted from the column by the addition of 7 ml of O. 5 M sodium 
acetate. This eluate is collected in a 10 ml volumetric flask, 0. 2 ml of 
acetylacetone is added, and the solution is diluted to the 10 ml mark with 
acetate buffer at pH 4. 6. The flask is stoppered and is placed in boiling 
water for 10 minutes, then cooled to room temperature. To a 2. 0 ml 
aliquot of this solution is added 2. 0 ml of modified Ehrlich's reagent. 
The resulting solution is mixed and after 15 minutes its optical density 
at 553 mp is read against a blank. The blank consists of water treated 
in the same manner as the Dowex 50 eluate. 
~· 
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Haeger in 1957 using Mauzerall and Granick's technique, reported 
that workers exposed to inorganic lead have considerably elevated ALA 
levels in urine. Since then, numerous other investigators have shown 
elevated urinary ALA levels in cases of clinical adult plumbism and in 
adult workers exposed to lead (Haeger-Aronsen; 1960; de Kretzer and 
Waldron, 1963; Kleinstein et al., 1963; Efe, 1964; Cramer and Selander, 
1965; Cramer et al., 1966; deBruin and Hoolboom, 1967). 
Bonsignore et al. (19 65) and deBruin and Hoolboom (1967) have 
demonstrated an ·early decrease .in the activity of ALA· dehydrase in the 
blood of both adult workers and rabbits exposed tq lead and it appears 
likely that the accumulation of A LA in the urine of individuals exposed ~o. 
lead is due to an irihibition of the ALA dehydra.se loca;tedin red_bloocl .. ·- __ 
cells. Additional evidence that the increased excretion of ALA is due 
to an inhibition of A LA dehydrase rather than a stimulation of ALA.··· 
synthetase has been supplied by Gajdos and Gajdos-Torok (1964) and 
by Pecora et al. (1964). These investigators studied the activity of 
ALA synthetase in mitochondria isolated from hepatic tissue of lead-
. . . 
poisoned rabbits, guinea pigs, and rats and reported that the activity of 
this enzyme was not measureable in the lead-poisoned animals nor in 
the controls. Rimington (1961) has shown that the livers of both lead-
poisoned and control rabbits have similar ALA contents. 
~------------------------------~ 
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Urinary ALA levels have been reported to have a positive correlation 
with blood lead levels {Selander et al., 1966), urinary lead excretion 
(Haeger-Aronsen, 1960; Cramer and Selander, 1965), and clinical 
impression of lead intoxication (Cramer and Selander, 1965). Raised 
ALA levels in the urine have also been found to be closely correlated 
to raised ALA levels in serum {Saita and Moreo, 1961; Chiesura and 
Brugnone, 1963). Blood and urinary ALA levels remain significantly 
increased for up to thr~e years after cessation of lead exposure (Saita 
and Moreo, 1964). 
Ari increased ALA excretion has been reported to be an earlier 
sign of lead exposure than an increased. coproporphyrin excretion (Singer-
man, 1964; Djuric et al., 1966) and several investigators have stated 
that an increased ALA excretion is the earliest sign of an increased 
lead absorbance (Efe, 1964; Djuric et al., 1966). An i:r:icreased u.rinary 
A LA level also appears to be pathognomonic of elevated lead absorption 
since the only other conditions known to result in an increased ALA 
excretion are acute intermittent porphyria and certain liver diseases. 
Haeger-Aronsen (1960) determined the urinary ALA content of patients 
- ' . - -- ... 
with either biliary disease, acute hepatitis, cirrhosis of the liver, 
,,. 
----------------------------------------------------------------. 
34 
hemolytic anemia, pernicious anemia, malignant tumor, leukemia, 
diabetes mellitus, nephropathy, or drug intoxication. The concentration 
of ALA in the urine was normal in all cases except three. Two of these 
were patients with acute hepatitis and one was a man with bronchial 
cancer. Schlenker et al. (1964) determined the urinary ALA content 
of patients with Hodgkin's disease, cirrhosis, leukemia, multiple 
myeloma, sickle celL anemia, or cancer and the only patient showing 
an elevated urinary ALA. level was ~he one_ with cirrhosis .. Griggs 
. . ~ ~ . -·· 
(1964) compared the urinary ALA levels of patients with lead toxicity, 
acute intermittent porphyria, iron deficiency anemia, hemolytic anemia, . 
pernicious anemia,·· or liver disease· and· found that elevated levels are · 
seen only in patients with lead poisoning, acute: intermittent porphyria~ 
·and occasionally liver disease. 
. . . .. . . . I· .· .. 
Dantchev et al. (1964) have reported that adenosine-5-monophosphoric 
acid (AMP) and inosine proteCt red blood cells against destruction by 
lead. Brugnone and Galzigna (1963) administered AMP to lead-poisoned 
rabbits and obse_rved a decreased urinary excretion of ALA .. Lead-
poisoned rabbits were also treated with AMP plus pyridoxal phosphate and 
the decrease in urinary ALA excretion from these animals was more pro-
,,,. ________________________________ ____, 
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nounced than fro~ those treated with AMP alone. The ALA in the blood 
was found to follow the same pattern as the urinary ALA. Koziolowa-
Lipska and Gutniakowa (1966) administered AMP to patients with chronic 
lead poisoning but could not demonstrate any significant decrease in 
. . . 
urinary A LA excretion. 
Haeger-Aronsen (1960) studied the influence of temper9.ture, pH,· 
calcium disodinm edetate,and penicillamin_e on the :3.tal?ility of ALA.in __ 
human urine and reported that at pH levels between 4 and 7, urine can 
. ... - - . .·· - ~. ·- - . . . ' - . 
. be ~torea at +4°c in the da~k for at least th.ree weeks with~ut any 
decrease in the concentration of_ALA. At a higher pH, t~e concentraHon 
of ALA was found to fall. The concentration of-ALA in urine was found 
to remain unchanged after the addition of either calcium disodium 
edetate or penicillamine. Bossenmaier and Cardinal (1968) also studied 
the stability of ALA in human urine and reported that urine-having pH 
levels between 1 and 9 can be stored at -20°c for at least four weeks 
without any appreciable decrease in the concentration of ALA. The 
stability of ALA in frozen urine thus makes it possible to collect and 
store large quantities of urine samples prior to the determination of 
their ALA content and this would be a definite advantage if a screening 
program using urinary A LA levels for the detection of early lead 
exposure would be implemented. 
~---------------------~ 
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G. PORPHYRIA 
The porphyrias are metabolic disorders, mostly of hereditary nature, 
characterized by an increased excretion of porphyrins and of their precur-
sors. In the erythropoietic porphyrias the porphyrins are elevated in the 
bone marrow, while in the hepatic porphyrias they are mainly in the liver. 
1. -Erythropoietic Porphyrias -
a. Congenital porphyria or Gunther's disease_ 
Congenital porphyria is a very rare distur~ance. which _i_s c~aracterized 
by a marked photosensitivity and an increased excretion of uroporphyrin and 
~ -- -
coproporphyr!n~ predominantly of the uriphysiofogical s'-edes rtype (Goldberg 
- . . . . . . -- . . --
and Rimington, 1982). This disease can exist in utero and individuals 
possessing the genetic trait always develop symptoms before the age of six_ 
- -
years. The bio~hemical abnormality. appears to be lacking of uroporphyrino-= 
gen isomerase from red blood cells owing to :a gene defe-ct and -because of thi 
enzymic defect, series I porphyrins are released into the plasma and tissues 
The photosen-sitivity associated with .this disease is a result of the presence 
of these porphyrins in the epidermal layer of the skin. 
b. Erythropoietic protoporph-yria 
This condition was first reported by Magnus et al. in 1961 and is 
characterized by a mild photosensitivity arid by an increased fecal excretion 
r---------------i 
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of coproporphyin and protoporphyrin IX which are present in excess in the 
circulating erythrocytes. In contrast to findings in erythropoietic congenital 
porphyria, there is no excess of uroporphyiin in blood or excreta. 
2. Hepatic Porphyrias 
a. Acute intermittent porphyria 
This is the most important member of the group of porphyria diseases 
and is characterized clinically by abdominal and neurological symptoms 
which appear in acute attacks separated by latent phases (Goldberg and 
Rimington, 1962). · In the acute· and latent phases bf this disea·se and often 
in.st~tes of remission~ patientS' excrete in urine an excessive quantity of. 
porphob.tlinogen and ALA (Haeger, 1958). 
This .disease occurs in members o.f t.he same family and Waldenstrom 
in 1937 established it as a hereditary diseas~. The biochemical trait is. 
transmitted as an autoso.nial dominant characterfstic (Goldberg and-
Rimington, 1962) and the clinical manHestations are more frequent in females 
Goldberg and Rimington (1962) described fifty cases of acute intermittent 
porphyria and the most frequent age of onset was the third decade for 
females and the fourth for males. The youngest patient found was a girl 
eleven years· of age. 
The main symptoms of acute intermittent porphyria are abdominal 
pain, vomiting, constipation, peripheral paralysis, and psychological 
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disturbances and all these symptoms can be account~d for by the widespread 
neurological lesions (Goldberg, 1959) which can involve the central, periph-
eral, and autonomic nervous systems (Gibson and Goldberg, 1956). There 
is an absence of skin photosensitivity because in this condition the porphyrin 
precursors are the main excretory products. -
A possible mechanism for the increased quantity of ALA and porpho-
bilinogen eliminated in acute intermittent porphyria is that ~hereis n,qrmally 
- - -- -
a control or inhibitor of ALA synthesis in the liver, but this control breaks 
down in the diseased subject: Shemin (1960) found evidence for a neg.ative 
feed-back control of in vitro ALA s·ynthesis by prep~rations derived_ from 
Rhodopseudomonas spheroides. In these_ preparations, AL.A was; found to be · 
inhibitory to the system producing it. Granick (1965) stated that acute 
intermittent porphyria results in part from an increased synthesis of A LA 
synthetase due to a defective regulatory control mechanism governing the 
activity of the structural gene which does not sufficiently repress the 
formation of the enzyme. Tschudy et al. (1965) and Nakao et al.(1966) have 
recently reported that the Uvers from patie~ts. with acute intermittent 
porphyria have an increased A LA synthetase activity . 
. -
b. Hereditary coproporphyria 
This rare disease is transmitted as an autosomal dominant character-
istic and is characterized by an increased coproporphyrin III excretion 
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even during states of remission (Goldberg et al., 1967). The symptoms of 
acute attacks have been found to be very similar to those of acute intermit-
tent porphyria. 
c. Mixed porphyria or variegate porphyria 
This porphyria is common among persons of European ancestry in 
South Africa (Dean, 19-63) and is apparently inherited as a Mendelian .. 
dominant character. Acute attacks similar to those of acute intermittent 
porphyria occur most commonly in affected females, while photosensttivity 
is found in male members of the same family. Patients with South ·African 
porphyria have a high fecal porphyrin contenf in states of remission, with 
an increase in the urinary porphyrin, porphobilinogen, and ALA excretion 
during acute phases of the disease. The ph6tosensitiv1ty present in the· 
variegate porphyria is due to the accumulation in the body of photo<;Iynam. -
. . . . . , -:., ~. 
ieally active porphyrins. 
Rimington (1967) has isolatea hydrophilic porphyrins from the urine 
and feces of patients with mixed porphyria and has found that excretion· of 
these porphyrins is characteristic of mixed porphyria. Norm.al persons 
and patients with porphyrias of other types excrete these hydrophilic 
porphyrins only in trace amounts if at all. 
d. Symptomatic or acquired porphyria 
This nonhereditary type of porphyria is characterized by photo-
sensitivity and an absence of acute attacks. The excretion of porphyrins, 
r.-------------r 
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especially urinary uroporphyrin, is very high, while the excretion of 
porphobilinogen and ALA is usually normal. Several types of acquired 
porphyria have been described: (1) porphyria cutanea ta~da symptomatica 
(Waldenstrom, 1957); (2) Bantu porphyriC;t (Barnes, 1959); (3) Turkish 
porphyria (Cetingil and Ozen, 1960); and (4) porphyrin-producing hepatic ad-
enoma (Tio et al.. 1957). The porphyria which occurs in Bantus has been 
reported _to be due to the hepatoxic. effect of aduJterated dri_n~s brewetj. a11d 
sold in the urban areas, while the porphyda in Turkey was the result of the 
ingestion of bread made from hexachlorobenzene-treated.breaci. 
i. The adverse effect of drugs on patients with hepatic 
_porphyria 
Certain drugs when administered to patients with either acute · 
intermittent or mixed ·porphyria can worsen the ·course of the disease and 
also precipitate attacks in cases of la.tent porphyria. Patients with the 
genetic factor are very sensitive to these drugs and a very small amount has 
been found to cause a response. Waldenstrom (1939) and Goldberg (1959) 
reported that barbiturates not only precipitate attacks in persons with latent 
porphyria of the acute intermittent variety but they also seriously affect 
. - ~ .. 
the prognosis of the disease. Dean (1963) also found that barbiturates may 
precipitate acute attacks in persons with mixed porphyria. Patients with 
South African :i:nixed porphyria appear to be the most sensitive to barbiturates 
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those with acute intermittent porphyria less so, and those with hereditary 
coproporphyria even less (With, 1965). 
Sulfonamides, nonbarbit urate sedatives and anticonvulsants, griseo-
fulvin, an_d sex hormones have an been demonstrated to be capable of pre-
cipitating attacks of acute intermittent porphyria in patients possessing the 
genetic trait. Administration ot chloroquine to patients with symptomatic 
porphyria results in an increased excretion of urinary uroporphyrin. 
accompanied by transient fever, -tachycardia, and general malaise (Embree; 
1961; Cripps and Curtis, 1962). The increase in uroporphyrin excretion is 
not accompanied by an increased excretion of porphyrin precu·rsors and it 
therefore appears that chloroquine causes a ~elease of stored uroporphyrin 
from the liver {Sweeney et al., 1965h · Felsher and Redeker {196.6)hav·e 
reported results which are in agreement with the suggestion that chloro-
quine causes a release of uroporphyrin fr~m the liver rather than an 
increased synthesis of uroporphyrin by the liver. 
ii. Experimental hepatic porphyria 
Drugs such as 2-allyl-isoprqpylacetamide {AIA) and 3, 5-diethoxycar-
bonyl-l, 4-dihy~rocollidine (DDC) have been found to-induce experimental· 
hepatic porphyria in both rats and rabbits (DeMatteis and Prior, 1962). Por-
phobilinogen and A LA were increased in the urine after treatment with these 
drugs and this is the same biochemical picture as seen in human acute 
intermittent porphyria. Ockner and Schmid (1961) have demonstrated that 
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rats fed 0. 2% of hexachlorobenzene in their diet excrete large amounts of 
uroporphyrin and coproporphyrin and if the exposure is prolonged 
porphobilinogen also increases. This biochemical picture is similar to that 
seen in patients with cutaneous porphyria in southeastern Turkey with the · 
exception that in the latter case porphobilinogen was not ·increased in the 
urine. Certain drugs, therefore, when administered to animals appear to 
be able to produce porphy:i:'ic disturbances resembling.those present· in 
human porphyria. 
iii. Mechanism of drug induced porph,Yria 
Granick (1965)_ demonstrated that _porphyrog.enic drugs indu.ce de novo _ 
synthesis of A LA syrtthetase in culture-$ of chicken embryo liver. cells and 
this observation has now been confirmed in the whole animal (Narisawa and 
Kikuchi, 1965; Marver et al., 1966). A recent report by Granick (1966) 
stated that heme prevents the increased porphyrin production caused by.AIA 
in cultured liver cells and he suggested that heme inhibits the increased 
synthesis of ALA synthetase by acting as a specific co-repressor in the 
regulation of this enzyme. Porphyrogenic drugs may interact with the 
portion of the apo-repressor molecule that normally binds heme and compete 
with heme for this site. _ Heme wo_uldthep. be_ preyented from combin,ing 
with the apo-repressor and the operator gene would be kept open for con-
tinuous synthesis of them-RNA necessary for synthesis of ALA synthetase. 
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METABOLIC FATE OF ALA 
Trlcarboxylic 
Acid Cycle 
Succinate-gl ycine 
· Cycle 
. . · · a-Amlno-p~ketoadlpie acid., 
rHOOC-CH2~CH2 -ri-cHOJ. . ) . L o J -~ 
Ketoglutaraldehyde HOO ~ C-CH2-CH2 -C-CH2 NH2. 
j [O] ______ ... ,, . A . cl-Aminolevulllnic. acid 
HOOC- CH2 - CH2 - C-COOH 
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0 
a-Ketoglutaric acid Porphyrln 
SUCCINATE-GLYCINE CYCLE 
Source:· Schmid, R. 1966 The Porphyrias. In "The Metabolic Basis of 
Inherited Disease, Second Edition" (J.B. Stanbury, J.B. Wyngaarden, ·and 
D.S. Fredrickson, eds.), pp. 813-870. ·McGraw-Hill, New York; Shemin, 
D. 1955 The Succinate-Glycine Cycle; The Role of [' -Aminolevulinic Acid 
in Porphyrin Synthesis. In Ciba Foundation Symposium on "Porphyrin 
Biosynthesis and Metabolism" (G. E.W. Wolstenholme and E. C. P. Millar, 
eds.), pp. 4-26. J. and A. Churchill Ltd., London. 
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Shemin and Russell (1953) postulated a succinate-glycine cycle throug 
which A LA can be oxidized back to succinic acid and this oxidation would 
thus provide a pathway for glycine oxidation. The first step of this cycle 
is the deamination of ALA to c< -ketoglutaraldehyde· which then releases the 
ALA-carbon derived from glycine to form succinate. The ALA-carbon 
derived from glycine provides the o.< -carbon atom to ureido groups of 
purines, the $-carbon atom of serine, the methyl group of methionine, 
and forms formic acid (Shemin et al., 1955). 
I. PHARMACOLOGICAL EFFECTS OF ALA 
The symptoms of lead intoxication. and of acute intermittept porphyria 
are very similar. The clinical pictures are ch-aracterized by abdominal 
pain, constipation, vo.miting, nc:mabdominal p_ain, and paralysis (Dagg et al. , 
1965). In both diseases there is ·also a similar type of segmental demye-
lination of the peripheral nerves. Secondary axonal degeneration found in 
experimental lead poisoning by de Villa;.tercie (1929}ha;=; ~.lsq been de~cribed. 
by Gibson and Goldberg (1956) in cases of acute intermittent porphyria. 
Since A LA is increased in both the urine and blood of patients with either 
lead intoxication or acute intermittent porphyria, it is tempting to assume 
that A LA is responsible for the clinical pictures described above. 
Berlin et al. (1954) a~d Scott (1955) administered ALA to humans 
per os and Granick and Vanden Schrick (1955) and Jarrett et al. (1956) 
r __ · --~--------, 
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injected ALA into rats intraperitoneally or subcutaneously and the only 
pharmacological effect observed was a transient but marked photosensitivity. 
Jarrett et al. (1956) also showed.that ALA did not possess any pharmaco-
logical activity when tested in the anesthesized cat or with isolated guinea 
pig ileum. In the cat, ALA at a dose of 100 pg/kg body weight did not 
alter the heart rate or blood pressure and neither potentiated nor inhibited 
the responses to adrenaline or to nor-adrenaline. ALA at a dose of 100 pg 
in a 20 ml bath neither caused a contraction of the isolated guinea pig 
ileum nor effected the contraction produced by histamine, by acetylcholine, 
or by 5-hydroxytryptamine. On isolated rat's colon, the same dose of ALA 
had no effect and did not alter the response produced by acetylcholine or by 
5-hydroxytryptamine. 
This pharmacological evidence was strengthened when AIA was found 
to produce experimental porphyria in rabbits, rats, and fowls (Goldberg 
and Rimington, 1954-55). Animals injected with this drug excreted large 
quantities of ALA and PBG, yet showed no features similar to acute inter-
mittent porphyria in humans apart from constipation and loss of weight. In 
addition cases of latent acute intermittent porphyria are known to excrete 
large quantities of ALA and yet are symptomless. 
Recently, Feldman et aL (1969) reported that ALA causes a reduction 
in twitch tension in vitro on phrenic nerve stimulation of rat hemidiaphragm 
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preparations (ED50 of 7. 5 mM). When the miniature end-plate potential 
frequency was augmented with 20 mM K+. 7. 5 mM ALA reduced it by 26% 
and 15 mM ALA by 61%. Dual microelectrode studies showed that ALA 
caused a 3-fold increase in muscle membrane conductance and it was 
conCluded that ALA inhibits the neuromuscular acetyleholine release. 
J. PURPOSE OF THE DISSERTATION 
Lead poisoning in children is a major public health problem in large . 
cities. The possibility exists that this problem may be controlled by 
carrying out large-scale screening programs designed for the detection of 
early and potentially hazardous exposure to lead before the development of 
frank lead intoxication. Since numerous ~nv~stigators have reported that 
urinary ALA levels are increased in cases of adult lead intoxication and in 
lead-exposed workers, a study of urinary ALA levels of children suspected 
of lead ingestion was undertaken. ·This type of study employing urinary 
ALA as a possible indicator for early lead poisoning has never been carried 
out in children. 
The studies which were undertaken had three objectives. . . first, 
the modification and simplification of the method described by Mauzerall and 
Granick for the determination of urinary ALA levels, thus making the urinar 
ALA test a practical screening procedure for the early detection of increased 
lead absorption in children; second, making the urinary A LA test readily avail-
• 
able for use throughout the country; and th.ird, the initial correlation of the 
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urinary A LA test with the clinical incidence of childhood lead intoxication. 
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MATERIALS AND METHODS 
CHAPTER II 
MATERIALS AND METHODS 
A. PREPARATION OF REAGENTS 
1. Sodium acetate, 1. OM. 68 g of NaC 2H 3o2· 3H20 (J~ T. Baker 
Chemical Co., Phillipsburg, N. J. , catalog no. 3460) are dissolved and 
diluted with water to 500 ml. 0. 8% of boric acid is added as a preservative. 
2. Acetylacetone. Obtaine_d under the name of 2, 4-opentanedione 
(Eastman Organic Chemicals, Rochester, New York, catalog no. 1088) 
and used undiluted. 
3. Modified Ehrlich's reagent. 10 g of para-dimethylamino-
'benzaldehyde U.S. P. {Matheson Coleman and BeU, Norwood, Ohio. catalog 
no. 1606) is dissolved in 420 m.l of glacial acetic acid (E.T. duPont de 
Nemours and Company,· Wilmington, Delaware) and 80 ml of 70%perchloric 
acid (G. Frederick Smith Chemical Comp., Columbus, Ohio). 
B. PREPARATION OF ALA STANDARD 
1. Delta-aminolevulinic acid hydrochloride. Obtained from 
Calbiochem, Los Angeles, Calif. , catalog no. 1584. 
2. Acetate buffer, pH 4. 6. 5. 7 ml of glacial acetic acid and 
13. 6 g of NaC 2H 3o2 · 3H20 are diluted with water to 100 ml. 
3. A stock solution of ALA is prepared by dissolving 12. 5 mg of 
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ALA hydrochloride with acetate buffer, pH 4. 6 to a 100 ml mark. Each ml 
of stock solution c.ontains 125 }lg of ALA· HCl which is equivalent to 100 )lg 
of pure ALA. 
C. PREPARATION OF AN ALA STANDARD CALIBRATION CURVE 
(1). Six aliquots of the ALA hydrochloride stock solution (0. 01 ml, 
0. 05 ml, 0. 10 ml, 0. 20 ml, 0. 30 ml and O. 50 ml) are pipetted into test 
tubes and are used as working standards. 
Volume of standard 
stock solution 
0. 01 ml 
0.'05 ml 
o. 10 ml 
0. 20 ml 
·o. 30 ml 
0. 50 ml 
pg_ oJ AL~ per t()tal . 
reaction volume 
1 pg 
5 pg 
10 pg 
20 }lg 
. 30pg 
_50pg 
(2).. Dilute each of the working standards to 7. 0 ml with 1. Q M 
sodium acetate. 
(3). Pipet 7. 0 ml of·l. 0 M sodium· acetate into an empty test 
tube to be used as a reagent blallk. 
( 4). Add 0. 2 ml of acetylacetone to each test tube and mix. 
( 5). Place the test tubes in a_ boiling water bath for 10 minutes, 
remove, and cool to room temperature. 
. 
(6). Add 7. 0 ml of modified Ehrlich's reagent to each test tube, mix 
and let stand for 15 minutes for complete color development. 
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(7). Read the optical density of the standards corrected for the 
blank at 553 mp. in a spectrophotometer. The optical path of the cuvette 
is 1. 0 cm. 
(8). Prepare a standard curve by plotting the concentrations of the 
standards against their optical densities. 
1. Effect of Varying the Amount of Acetylacetone 
Ten sets of test tubes-with ·each set-consisting of a O. 05-ml. 0.10 ml. 
and 0. 20 ml aliquot of the ALA hydrochlori~e stock solution were employed 
in this experiment and each-tube was diluted to 7. 0 ml with 1. 0 M sodium 
. . . . . " ... -· - . .. - . 
acetate. Reagent blanks. were prepared for each of the ten sets of test tubes 
and to each set of tubes a different amount of acetylacetone was added (0. 01 
. -
ml, O. 05 ml. b.10 ml, 0. H>-ml, O. 20 ml, 0. 25 ml, 0.~3_0 ml, O. 40 nil, -0. 50 _-
ml, and 1. 0 ml). After thoroughly mixing each tube, they were placed in a 
boiling water bath for 10 minutes, then removed and cooled to room tempe:r:-. 
ature. Color_deve~<?pme~t \Vas attained with m<:>d~fied Ehrlicli's reagent_ and 
the optical densities of the A LA standards in each set corrected for the 
appropriate blank were determined. 
2. Effect of Changing the Boiling Time -
Six sets of test tube~ with each set consi~ting of a O. 05 ml, O_. 10 _ml,_ 
0. 20 ml. and O. 30 ml aliquot of the ALA hydrochloride stock solution were 
employed in this experiment and each test tube was diluted to 7. 0 ml with 
1. 0 M sodium acet-ate. Reagent blanks were prepared for each of the six 
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sets of test tubes and 0. 2 ml of acetylacetone was added to each test tube. 
The test tubes were then mixed and each set of tubes was placed in a boiling 
water bath for a different period of time (1 minute, 5 minutes, 10 minutes, 
15 minutes~ 20 minutes and 30 minutes). Color development of the pyrrole 
-
was attained with piodified Ehrlich's reagent and the optical densities of 
the A LA standards in each set corrected for the blank determined. 
3. Stability of the Color Developed with Modified Ehrlich's Reagent 
Six aliquots orthe ALA hydrochloride-stock -solution (O. 01 ml, 0. 05 ml, 
0.10 ml, 0. 20 ml, O. 30 ml,· and 0. 50 ml) were placed-in test -tubes- and after 
the appropriate steps, color development was attqined with modified Ehr-
1ich' s reagent. · The optical density of each tube corrected for the blank 
was determined 15 minutes and also 2 hours after- the addition of the modified-
Ehrlich's reagent. 
4. Stability of Refrigerated Modified Ehrlich's Reagent 
A solution containing 10 g of para-dimethylaminobenzaldehyde (DMAB) 
in 420 ml of glacial acetic acid was prepared and a ioo ml aliquot of this 
solution was removed. The remaining 320 ml was placed in a refrigerator 
where it was frozen arid stored for future experimentation. To the 100 ml. 
aliquot 19 ml of 70% perchloric acid was added and the formed solution con-
stitutes fresh modified Ehrlich's reagent. A standard calibration curve was 
prepared as described under the section "PREPARATION OF AN ALA STAN-
DARDCALIBRATION CURVE" and this fr-esh modified Ehrlich's reagent was 
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used for color development. A 100 ml aliquot of the glacial acetic acid sol-
ution containing DMAB was removed 5 days, 10 days, and 15 days after 
initiation of freezing and modified Ehrlich 1 s reagent was prepared from eac 
of the aliquots. An A LA standard calibration curve was prepared using 
each of the modified Ehrlich's reagents and the optical densities of the A LA 
standards were compared to one another. 
D. PREPARATION OF DISPOSABLE CHROMATOGRAPHY COLUMNS 
PREPACKED WITH AN ION-EXCHANGE RESIN 
In order to .isolate A LA from urine, the urine sample must first be 
passed through an anionic exchange resin which permits the A LA and urea 
to pass through while retaining porphobilinogen. The effluent passing 
through the anionic· resin must then be passed through a cationic exchange 
resin which retains A LA while allowing the urea to pass through. The 
anionic resin employed in the following experiments was AG l-X8, 100 to 
200 mesh, acetate ionic form. The cationic exchange resin was AG 50W-X4, 
100 to 200 mesh, hydrogen ionic form. 
A slurry of either AG l-X8 resin or AG 50W..,X4 resin was made in 
water using 3· g of the respective resin and 7 ml of water for each column to 
be prepared. A 10 ml aliquot of the slurry was then pipetted into the appro-
priate disposable plastic chromatography column (Bio-Rad Laboratories) 
with the aid of an automatic syringe and the resin was held in the column by 
a glass wool plug placed in the bottom cap of the column. A second glass 
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wool plug was placed on top of the resin in order to prevent distortion of 
the resin bed. Using this method a column measuring 2 cm in height and 
1. 6 cm in diameter resulted. 
E. PROCEDURE F.OR THE PETERl\/UNA TION OF URINARY A LA 
The ·procedure used for the determination of urinary ALA is illustrate 
in Figure 1 and is as follows: 
(1). Insert a dual disposable chromatographic _co!umn ~etup in, the 
support rack with the column containing the anionic AG l-X8 resin on top 
and the column containing the cationic AG 50W-X4 resin on-the bottom. 
(2). Wash the top column with 10 ml of water and allow to drain 
through both columns into the drain tray . 
. (3). · Apply 0. 5 inl of a random urine sample to the top column after 
having determined that the pH of the urine is 6 or befow. 
(4)~ Wash the top column three times with 10 ml of water and allow 
the water to drain through both columns. 
(5). Discard the top disposable column.· 
(6). Place the bottom colum.n in a test tube (20xl50 mm). Add 7. 0 m 
ofl. 0 M sodium acetate to the column and collect-the eluted A LA inthe test tube. 
(7). Discard the bottom disposable column and add 0. 2 ml of 
acetylacetone to the test tube and mix. 
(8). Place the test tube in a boiling water bath for 10 minutes. 
(9). Add 7. 0 ml of modified Ehrlich's reagent to the cooled test tube. 
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(10). Read the optical density corrected for the blank after 15 minutes 
at 553 mp in a spectrophotometer and determine the concentration of A LA 
in the ·urine sample from the standard calibration curve. Normal values 
of urinary A LA produce a faint yellow color, w:hile abnormally elevated 
values produce a distinct red color. 
For the urinary ALA analysis, disposable pipettes, test tubes, and 
columns were used. An automatic pipetting machine was utilized for the 
addition of water and sodhim·acetate to the columns. Figure 2 shows the 
·applicafron ·of the· urine samples to the columns and the utilization of a 
hand-operated continuous syrfoge type. pipetter for the application of the 
water and sodium acetate. Theprocedure for urinary ALA _ana1y_sis as 
described above has been found to permit one individual "to perform 200 
determinations of urina~y A LA in approJ\imately only 4 hours or as many as . 
1, 000 analyses in a normal work we.ek. 
· 1. Recovery of A LA fro in Columns 
Forty-three piggyback column units were employed in this experiment 
and O. 5 ml of an _aqueous solution (distilled water) containing 20 pg of A LA 
per ml was applied to each of 25 columns, while LO ml was added to each of 
the remaining 18. The procedure for the determination of the A LA. content 
of the solution was the same as described above for the determination of 
A LA in urine. The concentration of A LA in the aqueous solution was 
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determined from the A LA standard calibration curve and this value was 
compared to the known amount of ALA in the solution. The per cent· 
recovery of ALA from the columns was then calculated. 
To determine the recovery of ALA from urine, ALA was added to 
freshly voided urine, pH 4. 0-6. 0, from a normal individual in such a manner 
so that a O. 55 ml aliquot of the urine sample would contain 5 pg of added 
ALA +the normal ALA content of the urine, a 0. 60 ml aliquot would 
contain 10 pg of added ALA+ the normal ALA content of the urine, and a 
O. 70 ml aliquot would contain 20 ;ig of added ALA + the normal ALA content 
of the urine. Four columns each received a 0. 5 ml aliquot of the normal 
urine and 0. 55 ml, 0. 60 ml, and 0. 70 ml aliquots of the urine samples 
containing the added ALA. The per cent recovery of the added ALA was 
th~n determined. 
2. Variation between Duplicate Samples 
A O. 5 ml aliquot of urine from a normal individual was added to each 
of five piggyback column units, while a O. 5 ml portion of urine from an 
I 
individual with lead exposure was added to each of a second set of iive 
columns. The ALA concentration of both the normal and high ALA urines 
was determined by each of the five columns to which they were added and the 
variation in ALA values between the columns re~eiving the same urine 
samples calculated. 
r. 
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3. Effect of Varying the Mesh Size of the AG 50\iV-X~ Resin 
A 10 ml aliquot of water was passed through each of twelve columns 
prefilled with AG l-X8 resin, 100 to 200 mesh, and the time required for 
the water to pasg t?r~u~h ~ach column was noted. The time required for 
10 ml of water to pass through columns prefilled with AG 50W...;X4 resin of 
either 20 to 50, 50. to 100, 100 to 200, or 200 to 400 mesh was also deter-
mined. The AG l-X8 columns were then placed on top of the AG 50W-X4: 
columns forming piggyback column units. The piggyback units were then 
divided into three series each consisting of an AG l-X8 column on top of 
an AG 50W-X4 column of either 20 to 50, 50 to 100, 100 to 200, ·or 200 to 
400 mesh. The time required for 10 ml- of -water to pass through each of 
these piggyback column units was then determined. To each column in the 
first series, a 0. 5 ml aliquot of an aqueous solution (distilled water) · 
containing 20 )lg of ALA per ml was added. To each of the columns in the 
second series, a ·o. 5 ml aliquot of urine from a normal individual was added .. 
while each of the columns in the third series received a 0. 5 ml aliquot of 
uri~e from a lead:exposed ~ndividual. The piggyback column units were 
washed three times with 10 ml of water and the time required for each wash 
.. 
to pass through the column units was determine<:J. The top column 
containing AG l-X8 resin was discarded and 7. 0 ml of 1. 0 M sodium acetate 
was added to each of the bottom AG 50W-X4 columns. The time required 
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for the 7. 0 ml aliquot of sodium acetate to pass through each column was 
noted and the pH of the sodium acetate eluate was determined. Color 
development was attained as previously described and the recovery of A LA 
from the columns receiving the same sample was calculated. 
4. Effect of Urine pH- on the R.ecovery of ALA from Ion-Exchange 
Columns 
A O. 2 ml aliquot of an aqueous_solution containing 500 pgofALA per 
ml was added to each of 10 test tubes. To each of these tubes 9. 0 ml of 
normal urine, pH 5.1, was added and the pH of the urines was adjusted with 
hydrochloric acid and sodium hydroxide to either 1. 0, 2. 0, 3. O, 4. O, 
5. 0, 6. 0, 7. 0, 8. 0, 9. 0, or 10. 0. The total volume of each tube was then 
adjusted to 10 ml With norm«il urine. A 0. 5 ml aliquot oT urine from-each-
of the tubes was then added to a different piggyback column unit and the 
optical density of the ALA eluted from each column was determined as· 
previously described. 
Similar experiments using 1 M sodium carbonate and hy_drochloric 
acid and ammonium hydroxide and hydrochloric acid to adjust the pH of 
urine were also performed. 
F.. COLLECTION OF URINE SAMPLES FOR. THE CORRELATION OF 
URINARY ALA VALUES WITH CLINICAL IMPRESSION OF LEAD INTOXI:-
CATION 
1. Study Number_ 1 
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The first investigation was performed during the months of February -
April, 1967 and concerns 250 children living in high-incidence areas of lead 
poisoning in the city of Chicago who were found by the Chicago Board of 
Health Division of Laboratories to have an initial blood lead value greater 
than 40 pg/100 ml as measured by atomic .abso~ption .sp~ctrometry. The 
percentage distribution of the initial screening blood lead values of the 2 50 
children studied was 72% of the population between 40 and 59 pg/100 ml; 
13% between 60 and 69 )lg/100 ml; 8% between 70 and 79 pg/100 ml; 3% 
. between -80 and 99 pg/ioo ml; 3% between 100 andl49pg/!OQ ml; and-lo/~ __ 
between 150 and 200 pg/100 ml. Following the initial blood lead determinat~o~, . 
each c:hilc1 was referred to _the Ch_icago Boa.rd- of Health. Lead Clinic . 
-located at -Municipal Contagious Disease Hospital for clinical examination-
of possible increased lead exposure. The ages of the children studied 
ranged from 9 months to 6 years with the majority of children (83%) 
being between the ages of 1 and 4 years~ Of the children stuc:iied 11% were 
white and 89% nonwhite, 51 % male and 49% female. A random urine 
sample for the analysis of delta-aminolevulinic acid (ALA) was obtained 
from each child during as many clinical visits as was possible. A total 
number of approximately l,. 000 urine samples were analyzed for urinary 
ALA content. The random urine samples were collected usfng 15 ml 
capacity disposable plastic tubes and stored in the dark in a freezer 
r 
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prior to the analysis of urinary ALA. All determinations of urinary ALA 
were performed within 1 week after collection. Urinary A LA is extremely 
stable following the above storage procedure since it has been found that 
. ·- . 
keeping frozen urines in a dark freezer for a period of 1 year_ results in 
only a 5% decrease in the original ALA content. 
2. Study Number 2 
- -
Random urine samples were obtained during the months of May -
August, 1967 from a second group of children who had initial screening 
blood lead values greater than 50 pg/lOD ml and were examined for possible 
lead ingestion at Municipal Contagious Disease Hospital. . This group . · 
consisted of 534 children and a random urine sample was obtained from 
each child during as many subsequent visits to MCDH as was possible. 
. . 
~ sp~cia~ atte~pt_ was _made to_obtain _s_!IC<;!es_siveda}ly random urine sampl_e 
from all children receiving chelaHon therapy for lead exposure. A total 
number of 1, 831 urine samples from the 534 ehildren were analyzed for 
- urinary A LA content. 
G. CORRELATION OF URINARY ALA VALUES WITH CLINICAL 
IMPRESSION OF LEAD INTOXICATION 
Each child referred to the Chicago Board of Health Lead Clinic had --
a thorough history and physical examination as well as a number of the 
commonly employed laboratory tests for le_ad exposure. The clinical and 
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laboratory findings on each child's chart were summarized and compared 
with the corresponding urinary A LA level obtained. In addition, the 
presence or absence of a clinical diagnosis of lead ingestion in each child 
was compared with the urinary ALA level of the same child.· The examining 
physicians at the Chicago Board of Health Lead Clinic were in no instance 
aware of the urinary ALA level of the patient when arriving at a decision 
as to possible therapy for lead exposure, thereby permitting a single--blind 
type of clinical study to establish a relationship between urinary ALA levels 
and possible lead exposure. The administration of either calcium disodium 
edetate or penicillamine by the examining physician on the basisof all 
clinical and laboratory data except the urinary A LA level was taken as a. 
-
clinical impression of an increased lead exposure in the child. 
H. EPIDEMIOLOGICAL FIELD STUDY OF URINARY ALA LEVELS 
A total of 5, 000 plastic disposable urine collection tubes were 
distributed to nine Urban Progress Centers in order to determine the 
frequency of elevated urinary A LA levels in children residing in high-
incidence areas of lead poisoning in the city of Chicago. The location of 
the Urban Progress Centers ·are listed below. 
South Parkway UPC 
Woodlawn UPC 
Englewood UPC 
South Chicago Unit 
Division St. Unit 
4622 South Parkway 
· 1030 E. 63rd Street 
839 W. 64th Street 
9231 S. Houston Avenue 
1940 W. Division Street 
Montrose UPC 
Halsted UPC 
Lawndale UPC 
Midwest UPC 
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901 W. Montrose Avenue 
1935 S. Halsted Street 
3138 W. Roosevelt Road 
9 S. Kedzie Avenue 
A blood sample and a fresh urine sample were obtained from every child 
examined at the Urban Progress Centers. The urine samples were 
refrigerated after collection and were sent with the blood samples to the 
Chicago Board of Health. As the urine samples arrived at the Chicago 
Board of Health they were frozen and were picked up twice a week by our 
laboratory in order to determine their A LA content. The analysis of blood 
lead was performed by the Chicago Board of Health Division of Laboratories. 
The procedure as outlined to the technicians is as follows: 
1. Check the names on the tubes containing the blood samples, 
number each, and enter the names and numbers into the 
workbook. 
*2. Measure the volume of the blood sample with a pipette and 
add this to 5 ml of 20% trichloroacetic acid (TCA ). l\Il :<: well 
on a mixer and centrifuge 5 minutes at 2 500 RPM. I_';"C·cant 
the supernatant into a labeled 50 ml tube. 
3. Add 2. 5 ml of 20% TCA to the packed precipitate, resuspend 
by mixing and centrifuge 10 minutes at high speed. 
4. Pour this supernatant into the tube containing the first super-
natant. (AT THIS POINT THE SAMPLES MAY BE FROZEN). 
r 
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If the samples are to be run in the same day continue to step 
#5. 
Prepare standards having concentrations of 0. 2, 0. 4, 0. 8 
and 1. 0 parts per million. Place a 5 ml aliquot of each 
standard into a 50 ml tube, add TCA and then proceed to 
. step 5. 
**5. Adjust pH to 2. 2~2. 8 with Na.OH and TCA. 
. .. 
6. Add 1 ml of 1% (aqueous) ammonium pyr.rolidine dithioc~rba-
mat_e (APDC) made fresh each day.- Mix well. 
7. Add 2 ml methyl isobutyl ketone (MIBK) and mix well. 
8. · Centrifuge 3 mim1:te_s and then aspirate top layer. ·Read in 
atomic absorption spectrophotometer. . 
NOTES: The following are the settings for the atomic absorption spectro-
photometer: 
Slit width - variable from 0. 05 to 0. 31 
Support - compressed air (17-18 lbs I sq in) 
Triple pass · 
Hot mode with variac 
Fuel - Acetylene (1 - 1.1/ 2 lb.s I sq in} 
Elevator Height· - 2. 35 to 2. 4 (Adjust for greatest sensitivity). 
Lamp - ll ma to 15 ma. Wavelength - 283 mp 
Scale expansion - IX 
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All glassware and pipettes are put through a regular wash and then returned 
to the laboratory where they are washed with a 1:1 dilution of concentrated 
nitric acid. They are then rinsed several times with distilled water, 
rinsed with de-ionized water, and finally oven dried. All standards and 
solutions are stored in polyethylene bottles. 
>:< 10 ml of blood are requested but usually only 5 ml are received. 
Samples as small as 2 ml whole blood can be run satisfactorily, but 
with 2 ml there is no concentration factor and the result is multiplied 
by 2 1/2. . 
>:~~:< Use one drop of thymol blue (1 % in methanol) which is deep rose in 
TCA; the end-point is pale salmon. 
I. ANIMAL EXPERIMENTS 
1. Storage of Urine Samples 
The pH of each urine sample was tested by indicator paper and 
occasionally, when necessary, adjusted to a pH range of 4-6 by the 
addition of a few drops of glacial acetic acid. The urine samples were 
then frozen and stored for future analysis of ALA. Delta-aminolevulinic 
acid levels were determined employing the dual disposable chroma.to-
graphic columns as described previously. 
2. Urinary ALA Excretion of Rats Injected with Lead Acetate 
Six male Sprague-Dawley rats 90 to 100 days of age and weighing 
305 to 355 g were each placed in individual stainless steel metabolism 
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cages and urine samples were collected in continuous two hour portions 
with the aid of test tubes placed in a fraction collector. After collecting 
24 hours of normal urine, three rats were injected intraperitoneally with 
1 mg/kg of lead acetate and three with 15 mg/kg. The urinary ALA 
excretion of each rat was determined before and after the adniinistra:tion 
of lead acetate. 
3. · ··Urinary A LA Excretion of Rats Fed Lead Acetate-in.the· Dfet 
Six male Sprague-Dawley rats 60 days of age and weighing· 210 to 230 g 
were each placed in individual stainless steel metabolisrrt cages and the 24 
" . "'-....... __ 
hou.r -µrinary outputs of the rats were collected. After two days of collectin 
normal urine samples, three rats were fed, ad libitum, diets containing 
O. 1 % and three were fed diets containing 1 % lead acetate. The lead 
acetate diets were maintained for seven days and then the rats were 
returned to a normal diet (powdered Rockland Rat Diet). The urinary ALA 
excretion per 24 hour urine sample was determined for each rat. 
4. Effect. of Calcium Dis odium Edetate pn the Urinary A LA 
Excretion of Rats Fed a 1% Lead Acetate Diet 
Six male Sprague-Dawley rats 60 to 67 days of age and weighing.220 
to 265 g were each placed in individual stainless steel metabolism cages 
and their 24 hour urinary outputs were collected. After a three day control 
period, three rats were injected intraperitoneally with 200 mg/kg of calciu 
disodium edetate for three cons.ecutive days and then were fed a 1 % lead 
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acetate diet for seven days. The three remaining rats were fed a 1 % lead 
acetate diet for seven days and. were injected intraperitoneally with 200 
mg/kg of calcium disodium edetate during the fourth through seventh day 
of the lead acetate diet. The 24 hour urinary A LA excretion from each 
rat was determined. 
5. Effect of Various Metals on the Urinary ALA Excretion of Rats· 
Male Sprague-Dawley rats 90 to 95 days of age and weighing 280 to 
350 g were .each placed in individual st~inless steel metabolism cages 
and their 24 hour urinary outputs were· collected. After three days of 
collecting normal urine samples, va.rious metals were administered to the 
rats and each was administered as a sing~e intraperitoneal injection which 
corresponded to approximately one-half its LD 50 dosage.· Three rats were 
injected with each of the metals studied. The metals and dosages that 
were administereq c:i.re the following: lead acetate, 50 mg/kg; cadmium 
chloride, 4. 5 mg/kg; bariu,m chloride, 15 mg/kg; ferrous sulfate, 100 . 
mg/kg; zinc chloride, 19 mg/kg; strontium bromide, 500 mg/kg; copper 
sulfate, 15 mg/kg; arsenic pentoxide, 2 mg/kg; titanium dioxide, 500 mg/kg 
mercuric chloride, 2 mg/kg; and lithium chloride, 250 mg/kg. Tetraethyl 
lead was administered as a single oral dose of 10 mg/kg. The 24 hour 
urinary outputs of the rats were collected and the A LA levels were 
determined. 
r----------------------, ~-. 
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Most of the metals injected into the rats were bivalent (lead, cadmium, 
barium, iron, zinc, strontium, copper, and mercury) and were selected 
in order to determine the specificity of lead in causing an increased 
excretion of ALA in urine; Tetraethyl lead was admfoistered to- determine 
whether an organic form of lead is capable of increasing urinary A LA 
excretion. 
J. STATISTICS EMPLOYED FOR THE ANALYSIS OF-DATA· 
1. Standard Deviation 
s ~ ~ 
. J.N-T S = standard deviation sx2 = sum of the deviations .from the 
mean squared 
N = number of individual 
measurements 
2. Comparison of Paired Observations by the t-Test 
t = d 
s-d 
3. Correlation Coefficient 
r = SPXY 
J sx2sy2 
t = t ·value 
d = mean difference 
sa = standard error of mean 
difference 
= correlation coefficient r 
spxy· = sum of the cross products XY 
where X and Y are the deviations 
·sx2 
sy2 
from their respectiv~ means 
= sum of the deviations from the 
mean squared for group X 
= sum of the deviations from the 
mean squared for group Y 
67 
4. · Chi - Square Test 
x2 = [(ad-be) - N/?] 2 N x2 = chi-square 
(a+b) (c+d) (a+c) (b+d) N = total number of 
Number of Children 
Having_ Normal Urinary 
ALA Levels 
Number of Children 
Having Elevated 
Urinary ALA ·Levels 
Total 
subjects 
a; b, c. and d = components of a 
2X2 contingency' · 
table 
2X2 Cc;mtingency Table· 
White Children 
(a) 
857 
(c). 
22 
(a+c) 
879 
Negro Children 
(b) 
2507 
(d) 
190 
(b+d) 
2697 
.. 
Total 
(a+b) 
3364 
(c+d) 
212 
(N) 
3576 
. 
r 
CHAPTER ·III 
RESULTs·· 
CHAPTER III 
RESULTS 
A. MODIFICATION OF MAUZERALL AND GRANICK'S METHOD FOR 
THE DETERMINATION OF URINARY ALA 
The use of disposable plastic chromatography columns prefilled with 
ion-exchange resin has made the determination of urinary ALA.levels a 
practical laboratory procedure~ The average completion time for one 
individual to perform 40 measurements of urinary A LA has been found to be 
approximately one hour, while 200 measurements of urinary ALA requires -
only 4 hoµrs. Only six urinary ALA determinations could be performed in 
one day using the method described by Mauzerall and Granick~ · 
. Chad 1 presents a typical A LA standard caiihration curve obtained 
by followi~g the procedure described in the section entitled "Preparation of 
an ALA Standarc:l_Calibration Curve." Urinary ALA .concentrations up to 10 
mg/100 nil (10 ingo/o) can be determined from this curve without dilutfori of the 
final red-colored reaction mixture. · 
Chart 2 presents the effect on final color development of changing the 
amount of acetylacetone added to the ALA standards. Color development· 
of the formed pyrrole, 2-methyl-3-acetyl-4-(3-propionic acid) pyrrole, was 
attained with modified Ehrlich's reagent and maximal development resulted 
when 0. 10 ml of acetylacetone was added to the A LA standards. A decreased 
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color intensity was not noted until 0. 30 ml of acetylacetone was added. A 
volume of 0. 20 ml of acetylacetone was therefore chosen as the quantity 
to be used for the condensation of ALA in both the preparation of the 
standard calibration curve and in the procedure for the determination of · 
urinary A LA, 
Chart 3 presents the effect on final color development of varying the 
boiling time of the sodium acetate solution containing ALA and acetylace-
tone. Color development of the formed pyrrole was attained with modified 
Ehrlich's reagent and maximal development was found to occur when the 
sodium acetate solution was boiled for 5 minutes. The color intensity 
remained maximal even when the sodium acetate solution was boiled for 
periods up to 30 minutes. A 10 minute boiling pe!'iod was therefore 
chosen to be_used i~ tpe preparation of._the ALA standa~d calibration cl,.lrve 
- - . - . 
and in the procedure for the determination of urinary ALA. - -
Chart 4-presents the stability of the color developed with modified 
Ehrlich's reagent. The optical densities of the ALA standards when read 
15 minutes and 2 hours after the addition of modified Ehrlich's reagent are 
similar and thus t~e color formed with this reagent is stable for at leas~ 
2 hours. 
Table 1 presents the stability of refrigerated modified Ehrlich's 
reagent .. When glacial acetic acid solution containing DMAB is frozen for 
r---~ _______ ___, 
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periods up to 15 ~ays and is then used for the preparati?n of modified 
Ehrlich's reagent, the color of the A LA standards developed with this 
Ehrlich's reagent is exactly the same as that produced with fresh reagent. 
Table 2 indicates the expected results using the modified method for 
the determination of urinary ALA. The limit of detectability of ALA in 
urine is 0. 03 mg/100 ml; the sensitivity of the test is ().15 microgram; 
the variation between duplicate samples is.::!::_ 3o/o; the recovery of A LA from 
aqueous solution is 97%; and the recovery of ALA from urine is 93%. 
Table 2a presents the recovery of ALA from aqueous solution (distilled 
water) using the piggyback column. method. When aliquots containing either 
10 or 20 pg of ALA were placed on piggyback column units, the recovery of 
ALA was 94. 9 ::!::_ 5. 4% and 100. 0 ::!::. 3. 4%, respectively. Table 2b presents 
the recovery of ALA from urine using the piggyback column-method.·· When 
· 5, 10, and 20 )lg of ALA were added to normal urine samples, the percent 
. . · .. · 
recovery of the added ALA was 92. 9 ::!::_ 6. 8, 93. 5 + 9. 5, -arid 93. 9 + 5. 0, 
respectively. Table 2c presents the variation between duplicate samples 
using the piggyback_ column method. The_ concentration of A LA in the 
urine of a normal individual was 0. 31 ::!::_ 0. 02 mg/100 ml and in the _urine 
.of a lead-exposed in~ividual was 1. 63 ::!::_ 0. 05 mg/100 ml. The variability 
between duplicate samples was found to be ::!::_ 3%. 
Table 3 presents the results of changing the mesh size of the AG 
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50W-X4 resin. A 25% recovery of ALA was obtained from columns pre-
filled with AG 50W-X4 resin, 20 to 50 mesh. When the mesh was 50 to 
100, a 58% recovery of ALA was attained. Columns prefilled with 100 to 
200 mesh AG 50W-X4 resin yielded a 97% ALA recovery,· while columns 
containing 200 to 400 mesh gave a 94% recovery of ALA. Since the time 
required for 7. 0 ml of 1. 0 M sodium acetate to flow through the 20 to 50 
mesh column was. 54 seconds as compared to 4 minutes 33 seconds for the 
100 to 200 mesh, it a,ppea~s that the ~od.i.um acetate pa,s$e~ through t h.e 
·•• 
larger mesh columns so rapidly that it can not quantitatively elute off the 
retained A LA. .Jt was of interest tO note that the pH of the sodium acetate 
eluate ranged from 4. 57 to 4. 71 depending on the mesh size of the AG 
50W-X4 column. Mauzerall and G:ranick have stated that A LA should be 
condensed with acetylacetone at a pH of 4. 6 and using the presently 
described method for the determination of urinary ALA, the pH of the sodium 
acetate elu-ate is of such a niagnitud"e that it does not have to be adjusted 
prior to the addition of acetylacetone. 
Table 4 presents the effect of urine pH on the recovery of ALA from 
disposable ion-exchang~ columns. Urine samples having a pH of from 
1. 0 to 10. 0 were applied to piggyback column units and there-was found to 
be an essentially identical recovery of ALA from those columns which 
received urine samples with a pH of 1. 0 to and including 6. 0. However, 
when the pH of the urine sample was 7. 0 or above, a decrease in the 
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recovery of A LA was noted. It is therefore suggested that the pH of all 
urine samples applied to piggyback column units be 6. 0 or below. 
B. CORRELATION OF URINARY ALA LEVELS WITH THE CLINICAL 
IMPRESSION OF LEAD INTO XI CATION 
1. Study Number 1 
Table 5 presents the percentage distrilaution Qf urinary ALA levels 
obtained from 2 50 children suspected of lead ingestion as a result of having 
an initial blood lead value greater than 40 )lg/100 ml. A total of 187 · 
children (75%) were found to have a urinary ALA level less than 1. 00 mg/ 
100 ml, while 63 children (25%) were found to have a urinary ALA level of 
1. 00 mg/100 ml or higher. Following clinical examination with the physi- · 
cian unaware of the urinary ALA level of the patient, only 4 to 5 per cent 
of children with a urinary ALA level less than 1. 00 .:r_ng/100 ml were 
treated with chelating agents for lead exposure. However, 65 to 100% of. 
the children with urinary ALA levels· of 1. 00 mg/100 ml or higher re- · 
ceived chelation therapy for lead· exposure. This data indicates that the 
practical upper limit of normal for urinary A LA values in children is . 
O. 99 mg/100 ml. Since there was also an essentially linear increase in 
the incidence of chelation therapy with progressive elevation of the urinary 
ALA level from 1. 00 mg/100 ml to 10. 0 mg/100 ml, it seems feasible to 
classify urinary A LA levels in children according to the code indicated in 
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Table 5. Urinary ALA levels between O. 00 and 0. 99 mg/100 ml may be 
considered normal. Urinary ALA levels above 1. 00 mg/100 ml can be 
subdivided into five ranges with a l+ code corresponding to 1. 00 to 1. 49 
mg/100 ml, a 2+ code corresponding to 1. 50 to 1. 99 mg/100 ml, a 3+ code 
·corresponding to 2. 00 to 2. 99 rng/100 ml, a 4+ code corresponding to 
3. 00 to 5. 99 mg/100 ml, and a 5+ code corresponding to greater than 
6. 00 mg/ 100 ml. 
Table 6 presents a comparison of urinary ALA levels with the 
incidence of chelation therapy in 2 50 children with SU!;pected l_ead ingestion. 
The urinary ALA test was interpreted as being correctly negative when a 
child with a urinary-ALA level of foss than 1. 00 mg/10-0 ml was not treated . 
with chelating agents following clinical _examination. _ Th.e urinary ALA. 
test was interpreted as being correctly positive when a child with a 
urinary ALA level of l. 00 mg/100 ml or higher was administered chelating 
agents. The minimum criteri~ used for the clinical diagnosis· of increased 
lead exposure were two consecutive blood lead values greater than 60 pg/ 
100 ml coupled with either a definite history of pica or X-ray evidence of 
lead ingestion. Based upon an overall comparison of urinary ALA levels 
with the incidence of chelation therapy iri childr~n ".'ith suspected lead 
ingestion it can be stated that urinary ALA levels are 91 % accurate for 
the clinical diagnosis of increased lead exposure. The incidence of urinary 
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ALA being false negative is only 3%, while the incidence of urinary ALA 
being false positive is only 6%. 
Table 7 presents a comparison of the various laboratory tests for 
lead exposure in 250 children with suspected lead ingestion in terms of 
frequency of abnormal test results. Employing the single-blind type of 
- -
evaluation, 92% of all the children who were dis-charged without chelation 
therapy after clinical examin~tion were found to have normal urinary A LA 
levels, whereas 86% of all the children who received chelation therapy 
after clinical examinatipn had abnormally elevated urinary A.LA values. 
None of the other laboratory tests studied had a comparable degree of 
• 
accuracy for the detection of early lead exposure. 
Table 8 presents a comparison of the various laboratory tests for 
lead exposure in 2 50 -children with suspected lead -ingestion in terms of 
frequency of associated chelation therapy. Employing the sirigle-blind 
type of evaluation, 96% of all the children with a normal range of urinary 
A LA values were discharged without chelation therapy after clinical 
examination, whereas 76% of all the children with an abnormally elevated 
urinary A LA value did receive treatment for lead exposure following 
clinical examination. Again, none of the other tests studied could compare 
with the urinary A LA test in terms of accuracy of detection of early 
exposure in asymptomatic children. Following clinical examination, only 
22% of the children who originally had initial blood lead values greater 
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than 40 pg/100 ml as determined by atomic absorption spectrometry were 
treated with chelating agents for lead eA-posure. 
Table 9 presents a comparison of mean urinary A LA values with 
mean blood lead values in 250 children with suspected lead ingestion clas-
sified by range of urinary ALA levels. Each blood lead value was deter-
mined at the same time as the urinary ALA value. The mean blood lead 
value which corresponded to normal urinary ALA levels less than 1. 00 mg/ 
100 ml was 48)1g/100 ml. However, children with levels of urinary ALA 
ranging from 1. 00 to 1. 49 mg/10.0 ml had a mean bloo? lead value of S5 )lg/ 
100 ml. An increase in the urinary ALA level was accompanied by a 
statistically significant corresponding increase fo blood lead levels. The 
significance for the correlation coefficients between mean urinary ALA and 
mean blood lead values was P < 0. 001 for normal, l+, 2+, and 3+ urinary·· 
ALA levels with P.( O. 01 for 4+ and 5+ urinary ALA levels.-
Table 10 presents the distribution of hemoglobin levels in children 
suspected of lead ingestion classified by urinary ALA levels. Of the 57 
children with elevated urinary ALA levels, 22% had abnormal hemoglobin 
levels (less than 10 g/100 ml). Of the 166 children having normal urinary 
ALA levels, 16% had hemoglobin levels less than 10 g/100 ml. 
Table 11 presents the distribution of hematocrit values in children 
suspected of lead ingestion classified by urinary ALA levels.. Of the 180 
76 
children with normal urinary ALA levels, 18% had abnormal hematocrit 
values {less than ·33%). Similarly 18% of the 61 children with elevated 
urinary ALA levels had hematocrit values less than 33%. 
2. · Study Number 2 
Table 12 presents the percentag€ distribution of urinary ALA levels 
in children with suspected lead ingestion as a result of having an initial 
blood lead level greater than 50 )lg/100 ml as determined by atomic 
absorption spect:rometry. A total of 371 children (69. 5%) had a urinary 
ALA level less than 1. 00 mg/100 ml, while.163 (30. 5%) had a urinary ALA 
level above 1..00 mg/100 ml. . 
Table 13. presents a comparison of elevated urinary AL..A. levels.with 
the incidence of chelation therapy in children suspected of lead ingestion 
as a result of having an initial blood lead value greater than 50 pg/100 ml. 
As in the first study, in no instance was the examining physician awa!'.e of .. 
the urinary ALA values when prescribing chelation therap.f. The minimum 
criteria used for clinical diagnosis of increased lead exposure was also 
the same as before. A total of 131 children were found to have urinary 
ALA levels of 1. 00 mg/100 ml or higher and 68. 4· to 100% of these children 
received chelation thera.py for lead exposure. These results are in 
accord with those obtained in the first study in which 65 to 100 % of the 
children with urinary ALA levels of 1. 00 mg/100 ml or higher were treated. 
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Table 14 presents a comparison of elevated mean urinary ALA values 
with the corresponding mean blood lead values in children with suspected 
lead ingestion. Each blood lead value was determined at the same time as 
the urinary ALA value. The mean blood lead value which was found to 
correspond to urinary ALA levels ranging from l. 00 to 1. 49 mg/100 ml was 
- . -·- - . . . -
60 )lg/100 ml. The mean urinary ALA level which was found to correspond 
to this 60 pg/100 ml was 1. 27 mg/100 ml. The mean blood lead levels 
which were found to correspond to mean urinary ALA levels of 1. 67, 2. 41, 
4.10 and 7. 97 mg/100 ml were 74, 80, 95, and.127 pg/100 ml respectively. 
Chart 5 indicates ·the typical response obtained when either calcium 
disodium edetate, abbreviated as EDTA, or penicillamine, abbreviated as 
PNCM, were administered to children with elevated urinary ALA values. 
It was found that both calcium disodium edetate and penicillamine admin-
istration resulted in a rapid return to normal of previously elevated urinary 
ALA levels. A child with an initial urinary ALA level of 4. 50 mg/100 ml 
after being injected intramuscularly with EDTA for five successive days 
at a dose of 50 mg/kg per day was found to have a norrp.al urinary ALA 
level on the fifth day of treatment. A similar decrease was noted when 
a child with an initial urinary ALA of approximately 2. 80 mg/100 ml was 
given penicillamine orally at a dose of 2 50 mg per day for 14 successive 
days. 
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C. EPIDEMIOLOGICAL STUDY OF UEINARY ALA LEVELS 
Table 15 presents the results of an epidemiological study to determine 
the frequency of abnormal urinary ALA values in apparently-well, asymp-
tomatic children residing in high-incidence areas of lead poisoning in the 
city of Chicago. Random urine samples from a total of 4, 189 children 
between the ages of 1and10 years were tested for urinary ALA content 
by the piggyback column method. A total of 5. 90% of the children tested 
had elevated urinary ALA values. Assuming that these results are 
representative of the entire population of approximately 260, 000 children 
residing in high-risk areas of the city. this data suggests a predicted 
number of 15, 340 children in the entire city of Chicago who should be 
strongly suspected of an increased exposure to lead on the basis of an 
abnormally elevated urinary A LA screening test. 
Table 16 presents the percentage distribution of the urinary ALA 
levels of the 4, 189 children according to the Urban Progress Centers where 
the children were examined. A total of 7. 6, 8. 9, 5. 6, 6. 6, 2. 3, 3.1, 4. 2, 
5. 8, and 8. 6% of the children examined at South Parkway UPC, Woodlawn 
UPC, Englewood UPC, South Chicago Unit, Division Street Unit, Montrose 
UPC, Halsted UPC, Lawndale UPC, and Midwest UPC, respectively, 
had urinary ALA levels of 1. 00 mg/100 ml or higher. The Midwest 
UPC had the highest percentage of children with elevated urinary A LA 
levels and it was found that 98. 3% of the children examined at this Urban 
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Progress Center were Negro. In contrast, the children examined at the 
Division Street Unit had the lowest incidence of elevated urinary ALA 
levels and only 5. 9% of the children examined at this Urban Progress Center 
were Negro. 
Table 17 presents the distribution of children with elevated urinary 
ALA levels by age. Of 227 children with urinary ALA levels of 1. 00 mg/ 
100 ml or higher, the highest percentage or 17. 2% were 4 years of age. 
Only 4 children or 1. 8% were in the 1 year age group. 
Table 18 presents the distribution of the urinary ALA levels of 3, 919 
asymptomatic children classified by age. It was found that 3. 9, 6. 9, 5. 3, 
5. 5, 4. 0, 6. 4, 6. 3, 5. 3, 7. 6, and 7. 9% of the children in the 1, 2, 3, 4, 5, 
6, 7, 8, 9, and 10 year age group, respectively, had urinary ALA levels 
of 1. 00 mg/100 ml or higher. The 10 year age group had the highest 
percentage of children with elevated urinary ALA levels. 
Table 19 presents the distribution of children with elevated urinary 
ALA levels according to race. In the epidemiological study, 24. 4% of the 
children tested were white, 74. 8% were Negro, and 0. 8% were classified 
as other. Of 214 children with urinary ALA levels of 1. 00 mg/100 ml or 
higher, 10. 3% were white, 88. 8% were Negro, and O. 9% were in the other 
category. 
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Table 20 presents the distribution of the urinary ALA levels of 3, 606 
asymptomatic children classified by race. A total of 2, 697 Negro children 
were tested and 7. 0% were found to have elevated urinary ALA levels. Only 
2. 5% of the 879 white children demonstrated an increased ALA excretion. 
The difference between the number of Negro- children having elevated urinary 
ALA levels and the number of white children is highly significant (P< 0. 001). 
Table 21 presents the distribution of the_ children with elevated urinary 
A LA levels according to sex. Of 4, 019 children tested, 52. 9% were males -
and 47.1% females. A total of 233 children had elevated urinary ALA levels -
- -
and of this total 62. 7%-were males and 37. 3% were fetnales. 
Table 22 presents the distribution of the urinary ALA levels of 4, 019 
asymptomatic children classified by sex. Of 2, 126 male children, 6. 9% had 
urinary ALA levels of 1. 00 mg/100 ml or higher. Only 4. 6% of the 1, 893 
- -
female children had elevated urinary ALA levels. The difference ·in the 
incidence of elevated urinary ALA levels between the two sexes is statistical-
ly significant (P< O. 005). 
Table 23 presents the distribution of blood lead values in 3, 068 children 
with normal levels- of -urinary A L..A.. Each blood lead value was determined 
at the same time as the urinary ALA value. Using a blood lead value of 
60 pg/100 ml as the upper limit of normal, 3, 031 out of 3, 068 children with 
normal urinary ALA levels also had normal ·blood lead levels. Only 37 
r-------------~:,:' 
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children with normal urinary A LA levels had blood lead levels greater than 
60 pg/100 ml . 
Table 24 presents the distribution of urinary ALA values in 3, i48. 
children with normal levels of blood lead. Only 2, 982 out of 3, 148 children 
with normal blood lead levels also had normal urinary ALA levels. A 
total of 166 children with normal blood lead levels were found to have 
elevated urinary A LA levels. 
D. ANIMAL EXPERIMENTS 
Chart 6 shows the typical response obtainetl when rats were injected 
intraperitoneally with a single dose .of either 1 mg/kg or 15 mg/kg of lead 
acetate. It was found that l mg/kg of lead acetate, shown by the open circles, 
• - - .~;...t;: 
did not cause an increased amount of urinary .ALA. On the other hand, 
15 mg/kg shown by the dark circles and equivalent to only 1/10 of the LD50 
of lead acetate was capable of causing an increase in urinary_ A LA within 
6 hours after injection, which reached a level of almost 5 mg/100 ml 24 
hours after injection. 
Chart 7 shows the effect on urinary ALA excretion of different con-
centratioris of lead acetate in ad libitum diets fed to adult rats. Within i ·day, 
a 0.1% lead acetate diet resulted in an elevation of the urinary ALA excretion 
from a control level of 50 )lg/24 hours to 96 )lg/24 hours. A 1% diet of lead· 
acetate was found to cause an increase in urin·ary ALA excretion from 
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50 to 400 pg/24 hours. The urinary ALA excretion remained elevated 
for the duration of the seven day feeding period of the lead-containing diet 
and was found to return to normal following the· removal of lead frorri the 
diet. 
Chart 8 shows the effect of calcium disoditim edetate on the urinary 
excretion of ALA in rats fed a 1% lead acetate diet. The top graph shows 
the elevation of urinary A LA caused by a 1 %- lead acetate diet as pre-
viously described.. The middle graph shows the urinary ALA excretion 
obtained when rats pretreated with calcium di sodium edetate were then fed 
. . 
a 1 % lead acetate diet. The rats were injected intraperitoneally with 200 
mg/kg of calcium disodium edetate fo~ three consecutive days prior to the 
onset orfhe 1% lead acetate diet. It was found that the calcium disodium 
edetate itself had no effect on the urinary ALA excretion of normal rats. 
In addition, the pretreatment of rats with calcium disodium edetate had no 
effect on the increase in urinary A LA. excretion resulting from a 1 % lead 
acetate diet. The bottom graph shows the urinary A LA excretion in rats 
fed a 1% lead acetate diet for seven days and which were also injected 
intraperitoneally with 200 mg/kg of calcium disodium edetate during the 
fourth thru seventh day of the lead acetate diet. .The urinary ALA level was 
observed to decrease from 424 pg/ 24 hours just prfor to the injection oi' 
calcium disodium edetate to 197 pg/ 24 hours following it. The urinary ALA 
excretion then remained depressed for the remainder of the seven day· 
r 
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period of lead acetate feeding. 
Table 25 indicates the effect of various metals on the urinary ALA 
excretion in adult rats. Each metal was administered as a single intra-
peritoneal injection which corresponded to approximateiy one-half its 
LD50 dosage. Tetraethyl lead, on the other hand, was administered as a 
. . 
single oral dos.e of 10 mg/kg. On Day O which was the day preceding admin-
istration of the various metals, the mean urinary ALA excretion per 24 
hour urine sample in 36 adult rats was 37 )lg with an upper limit of normal .. 
of 69 pg. Mean values of urinary ALA on Day 1 following injection of lead 
<:i.cetate rose to 291 pg, remaining elevated throughout the time periods 
studied. The difference between the urinary A LA levels obtained the day 
before and the day after the injection of lead acetate is statistically signifi-
cant (P ( O. 05). Tetraethyl lead, which _is an o_rganic form of lead, did not 
cause any inc:rease in the urinary ALA excretion of treated rats. I.n addition, 
none of the other metals studied, including cadmium, barium, iron, zinc, 
strontium, copper, arsenic, titanium, mercury, and lithium were found to 
produce a statistically significant increase in urinary ALA excretion. 
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A. CHILDHOOD LEAD POISONING AS A PUBLIC HEALTH PROB.LEM 
Lead poisoning in children is one of the major public health problems 
in large cities. In a three year period, 1959-1961, lead poisoning accounted 
for 4. 7% of 9, 853 cases of accidental poisoning in children reported to the 
Chicago B.OB;rd of Health, but was re$ponsible for nearly 80% of all deaths 
due to accidental poisoning (Christian et al., 1964). Of 61, 167 poisonings 
reported to the New York City Poison Control Center between 1955 and 
1963, 3% or 1, ·704 cases were due to lead (Jacobziner, 1966). In Baltimore 
from 1956 through 1964 there were 1, 337 known cases of lead poisoning in 
children (Schucker et al., 1965). 
New York City reported a 6. 3% mortality rate for childhood lead 
poisoning from 1954-1964 (Jacobziner, 1966). In Cleveland, Griggs et al. 
(1964) reported that from 1952 through 1958 lead poisoning had a mortality 
rate of 30%. Between 1959 and 1963, a mortality rate of 25% was reported for 
a group of 182 children treated for acute lead encephalopathy at Cook 
County Children's Hospital in Chicago and this fatality rate occurred despite 
the use of chelating agents and other techniques for reducing the intracranial 
pressure. Perlstein and Attala (1966) have found that in childhood lead 
encephalopathy, the mortality rate is between 28 and 45%, and four out of 
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five who survive have sequelae. This sequelae includes mental retardation, 
recurrent seizures, cerebral palsy, and optic atrophy. Recurrent seizures 
in their study was the most common sequela and occurred in 54% of the 
surviving patients, while optic atrophy was the least common having occurre 
in only 6%. 
Lead has become a major cause of poisoning among children, particu -
larly those residing in the slum areas of large cities. High risk areas for 
lead poisoning exist in all large cities and these areas usually contain old, 
dilapidated substandard homes. In such homes children have a ready 
access to flaking paint and broken plaster and due to a lack of parental 
supervision these homes provide an excellent environment for lead poisoning. 
The problem of lead poisoning is not, however, confined to the children in 
the lower socio-economic groups since it has also been reported in children 
from advantaged homes (Moncrieff et al. , 19 64). 
Children between the ages of 1 and 6 are the main victims of lead 
poisoning with those between 1 and 3 years comprising nearly 85% of the 
cases (Jacobziner, 1966). The two year age group contains nearly 54% of 
all deaths due to lead intoxication. Jacobziner (1966) in his epidemiological 
study of childhood lead poisoning found no significant difference in the 
mortality incidence based on sex, except among whites. Here, deaths of 
females outnumbered males two to one, however, the total number of deaths 
were too few to warrant any conclusions as to whether the female is more 
, 
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vulnerable. 
Lead poisoni.ng and lead encephalopathy in children are most frequently 
encountered during the summer months. About 45% of the total number of 
childhood lead poisoning cases reported in New York Citybetweenl954and1963 
were found to occur between the months of June and September (Jacobziner, 1966) 
Christian et al. {1964) have reported that80to 85%ofthe cases of childhood lead 
poisoning occur during these months. Lead poisoning, however, should not 
be considered. strictly a summertime_. di_sease since a number of cases have 
also been reported during th~ winter months._ Epidemiological. studies 
indicate that even though lead encephalopathy occurs more frequently during 
the summer, asymptomatic lead poisoning is a year round disease. The 
reasons postulated for the seasonal variati()n in the number of lead poisoning 
cases reported include= l} a metabolic disturbance caused by the actinic 
rays of the summer sun which results in an increased lead absorption; artd 
2) a greater opportunity during the summer months to ingest lead containing 
paint used on the exterior surfaces of the home (Jacobziner, 1966). 
B. USE OF SCREENING TESTS FOR THE DETECTION OF EARLY LEAI 
EXPOSURE 
Lead poisoning will only be wiped out when old housing is eliminated 
and new homes employing lead free paint constructed. Since at present this 
task is not possible, the best approach to the control of lead poisoning in 
children would be the carrying out of large-scale screening programs 
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designed for the detection of early and potentially hazardous exposure to 
lead prior to the development of the symptoms of frank lead intoxication. 
The Chicago Board of Health has been able to obtain an average of 2, 000 
venous blood samples per month from children residing in high-incidence 
areas of lead poisoning in the city of Chicago as part of their blood lead 
screening program. This rate of collection would only be able to screen a 
total of 24, 000 children per year and since there are at least 260, 000 
children between the ages of 1 and 7 residing in these high-risk areas. an 
annual screening program of only 24, 000 children does not seem adequate. 
Another disadvantage to the implementation of a blood lead screening pro-
gram is that the drawing of blood and the determinatfon of the lead content 
in the blood both require highly skilled personnel. 
In 1956 Mauzerall and Granick developed a colorimetric method for the 
determination of the ALA content in urine. Using this method Haeger-
Aronsen (1960) found that the concentration of urinary ALA is increased in 
adult workers exposed to lead. Several other investigators have also 
demonstrated that urinary ALA levels are increased in cases of lead poison-
ing and in lead-exposed workers (deKretzer and Waldron, 1963; Kleinstein 
et al.. 1963; Efe, 1964; Cramer et al., 1965; Cramer et al, 1966; deB:rroin 
and Hoolboom, 1967). 
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Urine cont~ins glucosamine and aminoketones and these compounds 
represent potential interfering substances in the determination of urinary 
A LA. Shuster (19 56) reported_ that both glucosami~e and aminoketones 
resembling ALA when heated with ethyl acetoacetate give condensation 
products which react with para-dimethylaminobenzaldehyde to form colored 
complexes. However, the relative molar color yield of glucosamine and 
_most of the aminoketones was much less than-that of ALA._ 
Mauzerall and Granick (1956) separated by paper chromatography the 
Ehrlich positive products associated with the determination of ALA in 
- - - - ~ -
normal urine and found that only 10 to· 20% of these products was the pyrrole 
corresponding to free ALA. Another-20 to 40% behaved as the pyr;role 
corresponding to an aminoketone withou~ ~free carboxyl grolJ.p e.g. amino 
acetone and the remainder was an orgairlc solvent -insoluble inaterial such as 
might be formed from glucosamine. Shuster (1956) has shown that using the 
ethyl acetoacetate method both aminoacetone and glucosamine give only a 
10% relative molar color yield as com1fared to ALA~ Mauzerall and Gran-
ick's method for the determination of urinary ALA uses condensation-with 
acetylacetone at a pH of 4. 6 and "this method is less sensitive than the ethyl 
acet9acetate method to color ~nterference with high concentrations of amino 
acids, ammoniaj or glucosamine." Thus, even though only 10 to 20% of the 
total Ehrlich positive products in normal urine are du~ to the pyrrole 
89 
corresponding to free ALA, the color intensity of this 10 to 20% would be 
far greater than that of the sum of the other products. Haeger-Aronsen 
(1960) has found that essentially all the A LA-like substances occurring in 
increased amounts in urine from lead workers is ALA. 
C. URINARY ALA LEVELS OF CHILDREN SUSPECTED OF AN 
INCREASED LEAD EXPOSURE 
The choice of urine as the- biological sample to be used in a screening 
program for the detection of early lead exposure in children has the 
advantage that a large number of samples could easily be obtained .. There-
fore, after reading the above reports it was deemed of interest to investi-
gate the urinary A LA levels of children suspected of an increased lead 
exposure. The method described by Mauzerall and Granick was utilized,· 
however, it was found that only six urinary ALA determinationscould be 
performed in one working day. The method of Mauzerall and Granick was 
modified and the present study indicates·that the determination of urinary 
ALA levels is now possible as a practical laboratory procedure. As shown 
in Figure 3, a complete kit for performing the analysis of urinary ALA is 
now commercially available and utilizing this kit one individual can perform . 
either 40 analyses of urinary ALA in one hour or approximately 1, 000 
analyses in a normal work week. The collection, handling, and storage of 
large numbers of urine specimens has been found to be feasible because only 
0. 5 ml of a random urine sample is adeq_uate for the quantitation of urinary 
r. 
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ALA. 
Cramer and Selander (1967} have reported that collection of 24-hour 
urine specimens is not necessary for the accurate quantitation of urinary 
ALA slnce the ALA values expressed in mg/100 ml from freshly voided urine 
specimens closely agree with those from 24-hour specimens. The AL.A 
output expressed in mg/ g creatinine in freshly voided urine was also found 
to closely correlate with the values obtained from 24-hour specimens. When 
the urinary ALA output expressed in mg/100 m_l was compared to ALA out~ 
put expressed in mg/ g creatinine a strong positive correlation was obtained. 
This thus indicates that it is not necessary to relate the urinary output of 
ALA to the output of creatinine or to the specific gravity orurine. 
Haeger-Aronsen (1960) collected freshly voided urine samples from 
. -
.. 
100 apparently healthy individuals (50 males, 50 females}, 20 to.65 years of 
age, and reported a mean urinary ALA concentration of O. 29 mg/100 ml 
with a standard deviation oJ o: 14. The 95% confidence limit was found to be 
0. 01-0. 57 mg/100 ml. Davis and Andelman (1967) reported that the normal· 
urinary ALA level in children ranging in age from 9 months to 5 years aver-· 
aged O. 22 mg/100 ml with a standard deviation of 0.16 mg/100 ml and a 95% 
confidence limit of O. 54 mg/100 ml. 
In the present clinical s~udy only 4 to 5%. of !he children with uri~ary 
A LA levels less than 1. 00mgI100 ml were treated with chelating agents for lead 
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exposure. This data indicates that the practical upper limit of normal 
for urinary ALA values in children is O. 99 mg/100 ml. Since the incidence 
of chelation therapy was found to increase as the urinary ALA levels in-
. . 
creased, it was possible to subdivide the ALA levels of 1. 00 mg/100 ml and 
above into five ranges. A l+ ALA code corresponded to an ALA level of 
from 1. 00 to 1. 49 mg/100 ml, a 2+ code corresponded to 1. 50 to 1. 99 mg/100 
ml, a 3+ code corresponded to 2. 00 .to 2. 99 mg/100 ml, a 4+ code corre-
sponded to 3. 00 to 5. 99 mg/100 ml,· and a 5+ code corresponded to 6. 00 
mg/100 ml and above. 
A 91% agreement was found to exist between urinary ALA levels and 
the administration of chelation therapy to asymptomatic children suspected· 
of lead ingestion and this offers evidence that urinary ALA levels are useful 
as a screening technique for the detection of childhood lead exposure. The 
incidence of urinary A LA being false positive was only 6% and this might 
have been due to the fact that urinary ALA levels have been reported to be 
the earliest indication oflead exposure (Efe, 19"64; Djuric et al., 1966). Since 
the examining physician was unaware of the urinary ALA levels of the patients 
in this clinical study, he would not be expeeted to administer chelating 
agents in the absence of other signs of an increased lead exposure. 
When comparing the various laboratory tests available for determining 
increased lead exposure, it was found that none of these could compare with 
the urinary A LA test in terms of accuracy of detection of early lead exposure 
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in children. Employing the single-blind type of evaluation, 96% of all the 
children with a normal range of urinary A LA values were discharged without 
treatment after clinical examination, whereas 76% of all the children with 
abnormally elevated urinary ALA values did receive chelation therapy for 
lead exposure after clinical examination .. Only 22% of the children who 
originally had initial screening bload lead values greater than 40 pg/100 ml 
as determined_ ~-y ato_mic absor?tion spe_ctroID:etry_ w~re tr_eated _with 
chelating agents. 
When lead-poisoned children with elevated urinary ALA levels ·were 
. . -
treated with chelating agents, the ALA levels returned to normal limits 
within a few days. Haeger-Aronsen (1960) treated lead-poisoned adults and 
rabbits with chelating agents and also found that the excr.etion of ALA.in the. 
urine decreased after initiation of treatment. A return.of elevated urinary 
ALA levels to normal after treatment with chelating agents ha~ been r'eported 
by numerous investigators (Griggs, 1964; Koziolowa-Lipska and Gutniakowa, 
1964; Selander et al., 1966; Selander, 1967). Haeger-Aronsen (1960) and 
Selander et al. (1966) have also reported that the excretion of lead in urine 
increases soon after the administration of chelating agents. The fact that 
the recommended chelat:i.on therapy for lead poisoning causes an increased· 
excretion of A LA to return to normal limits provides additional evidence 
that urinary ALA determinations correctly indicate abnormal lead exposure 
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in children and adults. The use of urinary ALA determinations as a 
clinical index for following the therapeutic management of patients receiving 
chelating agents for lead poisoning, however, is questionable since urinary 
A LA 1 evels have been found to increase once chelation therapy has ended. 
Griggs (1964) has reported that the reduction in the excretion of ALA from a 
lead-poisoned patient treated with versenate was maintained for only a few 
days; within two weeks excretion had returned to pretreatment levels. Per-
haps the urinary ALA test is so seni:>itive the.t the small amount of l~ad Jeft_. 
in the body after chelation therapy is capable once again of increasing the 
urinary excretion of ALA. 
It is generally recognized that the upper limit· of normal values for 
blood lead in children approximates 60 pg/100 ml, with a level of 80 pg/100 
ml or higher being indicative of frank lead intoxication (Smith, 1964; Green-
gard, 1966). The data from this study -indicates that urinary ALA values·be-"-
low 1. 00 mg/100 ml which are considered normal values were associated 
with blood lead levels which averaged below the accepted upper limit of nor-
mal of 60 pg/100 ml. Urinary A LA levels above 1. 00 mg/100 ml which are . 
considered abnormally elevated values were associated with blood lead values 
above 60 pg/100 ml. In the present study, children with a mean urinary ALA 
level of 1. 22 mg/100 ml had a mean blood lead_ level of 65)1g/100 ml. _Selan-
der et al. (1966) have found that in lead-poisonedadultsaleadlevelof60pg/ 
100 ml blood corresponded to an A LA value in urine of 2 mg/100 ml. 
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It should be noted that the highest mean elevated value of urinary A LA 
represents almost an eighteenfold increase over the mean normal value of 
urinary ALA, while the highest mean elevated value of blood lead represents 
only a threefold increase over the mean normal value of blood lead. 
Lead poisoning in adults usually results from the accidental exposure 
to lead in an industrial atmosphere, while in children is usually the result 
of oral ingestion of chips of lead-containing paint primarily in tlre older 
undercoats of paint. The chronic nature of lead poisoning enables the 
employment of a suitable screening technique carried out at periodic inter-
vals which would detect an abnormal exposure to lead prior to the .. develop-
ment of clinical symptoms. Since lead is rapidly stored in the skeletaLsys-
tern shortly after exposure of the child, initially high blood lead levels may quick!; 
decrease to normal values. This can occur even if the exposed child has 
an accumulation of potentially dangerous quantities of stored lead which can 
be released at any time to cause the severe manifestations characteristic of 
lead intoxication. Therefore, unless blood lead values are determined within 
a short period of time following exposure to lead, they may be of little value 
in any annual screening program designed for detecting early le~d exposure 
in asymptomatic individuals. Saita and Moreo (1964) have shown that A LA _ 
levels remain elevated for at least three years following removal of the 
r 
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individual from the source of lead exposure. This prolonged increase makes 
it possible for the use of urinary ALA measurements in annual screening pro 
grams for the detection of early lead exposure in asymptomatic individuals. 
An additional advantage for the use of urinary A LA levels as a screening 
technique is its low incidence of false-positive results. In contrast, the 
frequency of false-positive results obtained for abdominal x-ray films, 
hematocrit determination, -hemoglobin determination, wrist x-ray films, and 
blood lead values greater than 40pg/100 ml were 49, 64, 58, 68 and 78%, 
respectively. Coproporphyrin determination of urines obtained from 
asymptomatic children living in high-incidence areas of lead poisoning has 
been- reported to be 85% false positive (Davis and Andelman, 1967). 
Children with lead poisoning have been reported to demonstrate a 
pronounced microcytic, hypochromic anemia. In this study, however, 
children having elevated urinary A LA levels had similar hemoglobin and _ 
hematocrit values as children having normal ALA levels. It therefore 
appears that an elevated urinary A LA excretion occurs prior to the onset 
of anemia. 
D. URINARY ALA LEVELS OF ASYMPTOMATIC CHILDREN 
The results of the epidemiological study indicate that 5. 90% of the 
asymptomatic children residing in high-incidence areas of lead poisoning in 
the city of Chicago have urinary A LA levels of 1. 00 mg/100 ml or greater. 
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Since 260, 000 children reside in high-risk areas of the city, this data 
suggests that 15, 340 children in the city of Chicago should be suspected of an 
increased lead exposure on the basis of an abnormally elevated urinary A LA 
screening test. Of 227 children with urinary ALA levels of 1. 00 mg/100 ml 
or greater, 17. 2% were 4 years of age and only 1. 8% were in the 1 year age 
group. Even though lead poisoning has been reported to occur most fre-
the highest percentage of children having elevated urinary ALA levels is in 
the 9 and 10 year age groups. This latter result can be explained by the 
finding of Saita and Moree that urinary A LA revels may remain increased for 
up to three years after removal of the individual from O~e source of lead 
exposure. If children had ingested lead when they were 6 or 7 years of age, 
the A LA levels in their urine would ~emain elevated until the age of 10 .. 
· The epidemiological study showed that 7. 0% of the Negro children: 
tested had elevated urinary ALA levels, while only 2. 5% of the white 
children demonstrated an increased ALA excretion. This disparity is 
probably a reflection of the housing in which the children reside. Since 
. 
homes in Negro ghettos are more dilapidated than those in white neighbor-
hoods, it is entirely reasonable to see such a· high incidence of lead poisoning 
in Negro children. Dilapidated homes provide a ready access to broken, 
painted plaster from walls and paint peelings from window sills and ceilings. 
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Jacobziner (1966) has reported that in 90% of the cases of childhood lead 
poisoning, the affected child ingested chips of paint or plaster for several 
months prior to the diagnosis of lead intoxication. Since lead poisoning 
associated with pica is a chronic process, it becomes apparent that there is 
not only a necessity for new housing in slum areas but also a crying need 
for closer parental supervision of children. 
The epidemiological study also demonstrated that 6. 9% of the male 
children tested had urinary A LA levels of 1. 00 mg/100 ml or higher, while 
only 4. 6% of the female children had elevated urinary A LA levels. Jacob-
ziner .(1966) also found that more cases of lea:d poisoning occurred in males. 
In the present study, however, the· difference in the incidence between the 
sexes is statistically significant. 
E. EFFECT OF VARIOUS METALS ON THE URINARY ALA EXCRETION 
OF RATS · 
In the animal studies, rats were injected intraperitoneally with a 
single dose of 15 mg/kg of lead acetate and an increased urinary A LA 
excretion was demonstrated within 6_ hours. This dose represents only 
1/10 the LD50 of lead acetate and illustrates the rapid rise in the urinary 
ALA excretion after exposure to a low dose of lead acetate. Haeger-Aronsen 
(1960) found that rabbits injected subcutaneously with lead acetate at a dose 
of 125 mg/kg reached a maximum urinary ALA level on the thirty-fifth day 
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after injection when it was 1. 96 mg/100 ml. Rats injected with 15 mg/kg had 
, 
a value of almost 5 mg/100 ml 24 hours a,fter injection. The rat, therefore, 
appears to be an excellent animal to study the acute effect of chemicals and 
drugs on urinary A LA excretion. 
When each of sever al metals were administered to rats as a single 
intraperitoneal injection which correspom;led to one-half its LD50 dosage, 
inorganic lead was the only one found to cause an elevation of urinary A LA 
excretion. Tetraethyl lead, which was given orally, was found incapable of 
causing an increased urinary ALA excretion. Haeger-Aronsen (1960} 
injected rabbits with either· cobalt, copper, zinc, arsenic, ·silver, lead, tin, 
mercury' thallium, or bism?th and also found that lead was the only metal 
capable of increasing the ALA content of the urine. It was of particular 
interest to note that the administration o_f copper, mercury, and zinc did 
not increase the excretion of ALA by the intoxicated animals since Gibson 
et al. (1955} have demonstrated that in vitro these metals have a much stron-
~ --·-
ger inhibitory effect on ALA dehydrase than lead. If ALA dehydrase 
inhibition was the sole cause for increasing the ALA excretj.on, these other 
metals should also elicit an increased ALA content in the urine. A recent 
report by Heilmeyer (1967} sh~ws that the normal metabolism of ALA to Vt-
dioxovaleric acid (DVA} is inhibited in patients with lead intoxication. Shemin 
et al. (1953} were the first to show that ALA was metabolized to DVA and 
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perhaps the inhibition of this pathway is important. If lead causes a 
build-up of ALA by inhibiting the ALA dehydrase enzyme c;i.nd then also 
blocks the normal metabolism of ALA to DVA, there is no recourse but for 
ALA to be excreted as such in the urine. 
Goldwater and Joselow (1967) have reported that mercury-poisoned 
individuals have a normal content of A LA in the urine and this agrees with 
the rat data. _ Tetraethyl lead expo_sed individuals nave also been_ shown tq 
have normal urinary ALA levels (Koziolowa-Lipska and Gutniakowa, 1964; 
-., . 
Gherardi and Vidoni, 1965). It appears that only the inorganic form of lead 
is capable of eliciting an increased urinary excretion of ALA. 
F. DISADVANTAGES OF USING A SINGLE CATIONIC COLUMN RATHER 
THAN A PIGGYBACK COLUMN UNIT FOR THE ISOLATION AND DETER-
MINATION OF URINARY ALA 
The presently used method for urinary A LA determinations employs 
-two chromatography columns held in tandem position so that both the urille 
sample and the water washes can pass through both columns consecutively. 
The top column retains the porphobilinogen (PBG) and removes it as an 
interfering substance in the colorimetric determination of urinary A LA with 
Ehrlich's reagent. In two recent reports (Williams and Few. 1967; Sun et al.. 
1969) it has been suggested that acceptible estimates of urinary ALA might 
be obtained without prior removal of PBG and this is based on the assumption 
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that PBG is little affected by lead absorption. The available literature tends 
to indicate that PBG levels in the urine become increased with the onset of 
symptoms of lead poisoning. Griggs and Harris (1958), Haeger-Aronsen 
(1960). and deKretzer and Waldron (1963) have found that lead-exposed work-
ers have normal levels of PBG in urine. However, Bashour (1954). 
Tanabe (1959), Schlenker et al. (1964), and Gibson et al. (1968) have 
reported that PBG is increased in ~he uririe of lead-poisoned individuals. In 
addition to cases of lead intoxication, urinary PBG excretion has been repor-
ted to increase in diseases of the liver. including cirrhosis, as well as- a 
number of anemias other than those due to iron-deficiency (Saita et al., 1966). 
Williams and Few (19 67) state that their single column method might result 
in falsely high values in pathological conditions such as porphyria. The 
possibility therefore exists that measurement of urinary A LA levels with-
out the prior removal of PBG will result in a high incidence of false 
positives for_ lead exposure due to urinary increases of PBG. Since no 
additional time is required for the urine sample to pass through both a top 
anionic column which removes the PBG and a bottom cationic column which 
retains ALA for subsequent elution, a dual disposable column unit measuring 
urinary ALA levels alone is the method of choice. However. if urinary ALA 
- -
levels are used as a screening technique for the detection of early lead 
exposure in asymptomatic children. the cost of using the dual column units 
r 
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may be prohibitive. Since children do not demonstrate acute intermittent 
porphyria and liver diseases in childhood are rare, it may be possible to 
use a single disposable chromatography column containing AG 50W-X4 resin 
to obtain an acceptable estimate of urinary ALA for the early detection of 
childhood lead exposure. In industry where cost is not that important and 
the number of workers to be tested not that large , the use of the dual 
piggyb_ack .. column unit~ i_s recgmrriend_~cl· 
G. USE OF URINARY ALA LEVELS AS A SCREENING TECHNIQUE FOR 
THE DETECTION OF EARLY LEAD EXPOSURE 
In order to perform ·an annual urinary A LA screening program to 
detect early lead exposure, large numbers of urine samples would have to 
be collected. If 100, 000 random urine samples were to be· collected annually, 
it would be necessary to obtain random urine samples from approximately 
2000 children per week. This can be accomplished by utilizing the following-
sources for collecting urine samples frorn children: .. 1) community repre- -
sentatives as part of their normal assigned duties in visiting the homes in 
slum areas; 2) high-risk infant welfare stations; and 3) neighborhood health 
centers. The major responsibility in collecting urine samples should lie 
.. 
with the community representatives !epresenting the Urban Progress Centers 
With the large number of community representatives available at the 
Urban Progress Centers, each one would have to collect only a few urine 
samples per day in order to attain the desired 2, 000 urine sa:nJ.ples per week. 
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The utilization of the community representatives in obtaining the urine 
samples would not involve any additional expense since they would perform 
the collect_ion of urine samples du~ing the_ course of their normal visits. The 
only instruction necessary would be the proper labeling of the data-tab 
attached to the urine coliection tube. Each community representative would 
fill out the data-tab and then s!ip it aro'llnd the urine collection tube which 
is then filled with as little- as 1 to 5 ml of urine and stoppered. At the end 
of the day, the representatives would return their collected urine.samples 
to their respective Urban Progress Center where they would be placed in a 
freezer. The following day these urine samples would be brought to the 
laboratory where the determination of urinary ALA would be performed. 
The urin-e can be stored in a freezer pribr to the determination of its A LA 
content. 
The following is the presently recommended procedure for the collec-
tion and storage of random urine samples whose ALA levels are subsequent-
ly to be determined: · 
1. Place 0.1 ml of glacial acetic acid in an empty screw-capped 
vial in order to insure that the stored urine will have a pH below 6. 
2. Collect a random urine sample. It is advisable not to use the· 
first voided morning specimen, late evening specimens after 8:00 P. M .• or 
specimens obtained following excessive fl:µid intake. This eliminates any 
concentration or dilution of the urinary ALA content. · 
r 
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3. Add approximately 10 ml of the random urine sample to the 
vial containing the glacial acetic acid, replace the cap, and gently mix. 
· 4. Place the vial in a refrigerator or freezer as soon as possible. 
Excessive light exposure of the urine sample should be avoided prior to 
storage since ALA has been found to be light-sensitive. This can easily be 
accomplished by placing the via.ls in either a dark brown plastic bag or a 
light-tight box. The urinary A LA content of samples stored in a dark 
refrigerator will_ remain constant up to 4 months, while the urinary ALA 
content of samples stored in a dark freezer have been found to remain 
constant up to 1 year. 
5. After removal from storage, the urine in each vial should be 
.. 
gently shaken to provide a homogeneous sample from which.to pipet the . 
O. 5 ml aliquot required for the urinary A LA determination. 
In order to test 100, 000 children for urinary ALA levels per year, it is 
necessary that a total of 400 urinary ALA determinations be performed daily. 
'this can easily be accomplished by using the previously described method. 
A major advantage of the colorimetric determination of urinary A LA levels 
in the visible spectrum is that normal values of urinary A LA produce a 
colorless to faint yellow color, while abnormally elevated values of urinary 
ALA produce a definite and distinct red color. It is therefore possible in a 
large-scale screening program to immediately classif.y all non·red colors 
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as being normal A.LA values and determine only the optical densities of the 
few red colored samples. The optical densities of the samples can.be 
quickly converted to mg/100 ml (mg%) of urinary ALA by using a conversion 
chart as shown in Table 26. 
Table 27 classifies urinary ALA levels irt terms of their rela.ti6nship 
to lead exposure in children. Values of urinary A LA below 1. 00 mg/100 ml 
are considered to be normal, indicat~ng an insignificm:it .e:iq>QE;?..ure tQ Je~d .. 
Values of urinary ALA 1. 00 mg/100 ml or higher cari be considered to be 
abnormally elevated with five subdivisions of increasing severity. A l+ 
ALA code indicates a moderate exposure to lead; a 2+ indicates a heavy 
exposure to lead; a 3+ indicates a severe exposure to lead; a 4+ indicates 
a critical exposure to lead; and a 5+ indicates an overwhelming exposure ·to 
lead. The greatest·prlority should thus be given the children with highest 
urinary ALA levels. Children with urinary A LA levels corresponding to a 
code of 5+, 4+, 3+, and 2+ should be immediately referred to a hospital for 
clinical examination. Such a clinical visit might include not only a history 
and physical examination.· but also a blood lead determination, X-ray 
examination of both the abdomen and wrists, and hemoglobin and hematocrit 
determinations. If desired, the determin;:i.tion of urin<;i.ry coproporphyrin 
and basophilic stippling can also be performed. Children with a urinary ALA 
code of l+ should be scheduled for the earliest possible clinical examination 
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after all the children in the range of 2+ to 5+ have been examined and treated 
with deleading agents. 
In summary, the following are the major advantages of using the 
urinary A LA levels of asymptomatic children as a screening program for 
the detection of early lead exposure: 
1. The collection of random urine samples is the only practical 
method of obtaining biological specimens from thousands of small children. 
2. The determination of urinary ALA requires only O. 5 ml of a 
urine sample. 
3. ALA is stable in frozen urine for at least one year and there-
fore urine samples can be collected and stored without any decrease in 
their A LA content. 
4. On the basis of performing 400 urinary ALA determinations 
per day, 100, 000 urine samples can be analyzed for their ALA content per 
year. 
5. Urinary A LA levels are 91 % accurate for the clinical diagnosis 
of increased lead exposure in children based on a single-blind type of 
evaluation. 
6. Urinary ALA levels have a statistically significant relationship 
to blood lead levels in children (p .C. O. 001). 
7. Urinary ALA levels remain elevated up to 3 years following 
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exposure to lead, thereby permitting the implementation of an annual A LA 
screening program. 
8. Elevated urinary ALA levels return to normal within 3 to 5 days 
after calcium disodium edetate therapy and this indicates that urinary A LA 
determinations correctly reflect an abnormal lead exposure in both adults 
and children. 
9. The 5. 90% incidence of elevated urinary ALA levels found in the 
4, 189 children residing in high-risk areas of lead poisoning agrees with the 
predicted 6. 0% incidence of childhood lead poisoning based on the Depart-
ment of Health, Education, and Welfares' figures for urban areas. 
10. A cute intermittent porphyria and occasionally certain liver 
diseases are the only other pathological conditions besides lead poisoning 
which cause an increased excretion of ALA in the urine. Acute intermittent 
porphyria does not occur in children and liver disease in childhood is rare 
and therefore lead intoxication is the only known condition to cause an 
increased ALA content in the urine of children. 
11. Finally, the cost of determining the A LA content of urine is 
much less than the cost of performing most of the other laboratory tests 
commonly used for the detection of an increased lead absorbance, e.g. 
blood lead determination. 
r 
CHAPTER V 
SUMMARY 
CHAPTER. V 
SUMMARY 
1. The method for the isolation of urinary A LA from random urine 
samples has been modified utilizing a dual disposable chromatographic 
column unit prefilled with resin that can be conveniently held in a 
support rack over a drain tray. The method for the colorimetric 
determination of urinary ALA has been simplified by the elimination 
of a number of transfer and dilution steps. By using the presently. 
described procedure, one indivi.dual is able to perform without 
difficulty as many as 1, 000 analyses of urinary ALA in a normal 
working week. 
2. A single-blind type of evaluation was made of the laboratory findings 
and clinical impression of increased lead exposure versus the urinary 
ALA levels obtained in each of 250 children suspected of lead ingestion. 
In no instance was the examining physician aware of the urinary A LA 
level of the patient when deciding on possible therapy for lead exposure. 
It was found that urinary A LA levels are 91 % accurate for the clinical 
diagnosis of increased lead exposure in children. None of the other 
laboratory tests studied had a comparable degree of accuracy for the 
detection of early lead exposure. 
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3. It was found that a practical upper limit of normal for urinary ALA 
levels in children is O. 99 mg/100 nil. Elevated urinary ALA values 
have been subdivided into 5 ranges of increasing severity with al+ 
code corresponding to 1. 00-1. 49 mg/100 ml; a 2+ code corresponding 
to 1. 50-1. 99 mg/100 ml; a 3+ code cqrresponding to 2. 00-2. 99 mg/ 
100 ml; a 4+ code corres:ponding to 3. 00-5. 99 mg/100 ml; and a 5+ 
code corresponding to greate'r than 6. 00. mg/100 ml. 
4. A significant correlation was found to occur between levels of urinary 
A LA and levels of blood lead as determined by atomic ·absorption 
spectrometry in children suspected of lead ingestion. The mean blood 
lead values found to correspond to normal urinary A LA levels was . 
48 pg/100 ml. The mean blood lead values found to correspond to -
abnormally elevated urinary ALA levels ranged from 65 to 147 pg/ 
100 ml. 
5. The frequency of abnormal urinary ALA values in apparently-well, 
asymptomatic children residing in high-incidence areas of lead· 
poisoning in the city of Chicago has been determined. Of 4, 189 
children tested, a total of 5. 90% had elevated urinary ALA values.· 
Based upon this data, it has been predict~d that nearly 15, 000 children 
in the city of Chicago may suffer from an increased exposure to lead. 
6. In the epidemiological field study, the four year age group contributed 
,ij 
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the greatest number of children having elevated urinary ALA levels. 
Negro children with elevated urinary ALA levels outnumbered white 
almost nine to one and males outnumbered females almost two to one. 
7. Animal studies using adult rats indicate that a single intraperitoneal 
injection of 1/10 the LD50 of lead acetate is capabie of causing an 
increase in urinary ALA excretion within six hours. 
8. Tetraethyl lead was not capable of increasing the urinary ALA 
excretion of adult rats. 
9. Pretreatment with calcium disodium EDTA did not protect against an 
increase in urinary ALA excretion from adult rats subsequently fed 
lead acetate. However, caldum disodium EDTA when administered 
during the period of elevated urinary ALA excretion, caused a rapid 
fall in urinary ALA levels. 
10. Inorganic lead has been shown to be specific in causing an increased 
excretion of urinary A LA from adult rats with respect to 10 other 
metals tested (cadmium, barium, iron, z1nc~ strontium, copper, 
arsenic, titanium, mercury, and lithium). 
11. It is suggested that urinary A LA levels are the earliest and most· 
sensitive indicator of childhood lead exposure and that the- present 
development of a practical laboratory method for the analysis of 
urinary ALA can make possible bo~h large-scale screening for early 
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lead exposure in asymptomatic individuals as well as the routine 
determination of urinary ALA levels in all individuals suspected of 
lead intoxication~ The fact that about 15, 000 children in the city of 
Chicago alone might suffer from an increased exposure to lead 
emphasizes the need to carry out such large-scale .urinary ALA 
screening in apparently-well, asymptomatic children before the 
possible development of frank lead intoxication. 
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FIGURE 1 
INDIVIDUAL STEPS OF THE TEST PROCEDURE FOR THE RAPID ANALYSI 
OF URINARY ALA EMPLOYING PREFILLED DISPOSABLE PLASTIC CHRO-
MATOGRAPHY COLUMNS ARRANGED IN PIGGY-BACK FASHION 
111. 
FIGURE 2 
•\ 
Simplified system for the isolation of ALA from 40 sample s of urine 
employing t wo dis-posable plastic chromatographic columns in tande m 
-
position held by a support rack m e asuring 10 inches in length, 5 inches in 
width and 10 inches in, height. , Left, The top column contains an anionic 
·.--
. exchange resin consisting of AG l-X8, 100 to 200 mesh, in the acetate 
ionic form. · The bottom column contains_ a cationic exchange resin con-
sisting of AG 5.0W-X4, 100 to 200 mesh, in the hydrogen ionic form. 
The columns are situated in the support rack above a suitable drain tray. 
The urine sample is applied to the top column by inserting a pipette through 
tile numbered hole in the top removable plastic sample guide and, after 
passage through both columns , allowed to drain into the drain tray. Center , 
Following removal of the pla stic sample guide, the top column is 
FIGURE 2 
washed with water allowing the water to drain through both columns into 
the drain tray. Right, Following removal of the top column, the bottom 
columns are placed in numbered test tubes held in a standard test tube 
support rack. Elution of A LA from the bottom c olumn into th e test tube 
is then carried out with sodium acetate solution. 
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FIGURE 3 
COMPLETE KIT FOR PERFORMING THE ANALYSIS OF URINARY ALA 
FROM 40 URINE SAMPLES, INCLUDING DISPOSABLE PLASTIC CHROMA-
TOGRAPHY COLUMNS PREFILLED WITH AG l-X8 AND AG 50W-X4 RESINS, 
SUPPORT RACK AND NUMBERED PIPET GUIDE, DRAIN TRAY AND ALL 
NECESSARY REAGENTS. 
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TABLE 1 
STABILITY OF REFRIGERATED MODIFIED EHRLICH'S REAGENT 
Quantity of ALA per 
14. 2 ml Final Re-
action Volume 
2 µg 
5 µg 
10 )ig 
20 }lg 
30 µg 
50 ,ug 
OPTICAL DENSITY at 553 Il1)l 
Day O_ 
0.070 
0~168 
0.345 
0.670 
- 0. 940 
1. 45 
125 
Day 5 
0.070 
- 0. 163 
o. 3"52 
0.648 
0.900-
1. 45 
DayH.>,: "· 
0.065 
0.158 
0.335 
0.640 
>" 0.-925 
1. 45 
Day 15 
0.073 
0.110. 
0.355 
0.645 
0. 900 -
1. 40-
"1'1 
TABLE 2 
EXPECTED RESULTS USING THE MODIFIED METHOD FOR THE DETER-
MINATION OF URINARY A LA 
Limit of detectability of A LA in urine . 
Sensitivity of test 
0. 03 mg/100 ml 
0.15 )1g ALA 
Variation between duplicate samples. + 3% 
Recovery of ALA from aqueous. solution (distilled water) .. 97% 
Recovery of A LA from urine . . 93% 
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TABLE 2a 
RECOVERY OF ADDED ALA FROM AQUEOUS SOLUTION (DISTILLED 
WATER) USING THE PIGGYBACK COLUMN METHOD 
ALA Recovered (o/o) 
10 )lg ALA Applied 20 )lg ALA Applied 
to Column to Column 
87.5 106.3 
98.4 93.9 
98.4 99.8 
103. 2 101. 6 
94.7 103.1 
86. 8 97.2 
92.7 103.2 
101. 4 103.2 
103. 8 99.8 
103.8 96.5 
85.0 95.3 
92. 1 103.3 
98.4 96.8 
93.9 96.8 
100.0 100.0 
92.9 103.3 
96.4 100.0 
88.7 100.0 
87.2 
94.1 
95.5 
95.8 
94.1 
97. 1 
91. 2 
x 94.9 100.0 
S. D. + 5.4 +3.4 
-
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TABLE 2b 
RECOVERY OF ADDED ALA FROM URINE USING THE PIGGYBACK 
5 pg A I...A A pp_lied 
to Column 
92.6 
87.9 
102. 5 
88.5 
x 92.9 
S. D.+6. 8 
COLUMN METHOD 
ALA Recovered(%) 
l~pg ALA Applied 
to Column 
89.2 
91. 6 
107.4 
85.9 
93.5 
+9.5 
128 
20 pg ALA Applied 
to Column 
95.3 
95. 3 
86.7 
98.4 
93.9 
+5.0 
TABLE 2c 
VARIATION BETWEEN DUPLICATE SAMPLES USING THE PIGGYBACK 
COLUMN METHOD 
., 
I\ LA Recovered from Variation from ALA Recovered from Variation from 
Urine of Normal Mean(+%) Urine of Individual Mean(+%) 
Individual (mg/100 ml) With Lead Exposure 
(mgf 100 ml) · 
o. 31 0.0 1. 70 ' 4.3 
0.32 3.2 1. 60 1. 8 
0.27 12. 9 
' 
1. 61 1. 2 
0.32 3.2 1. 66 1. 8 
o. 31 0.0 1. 56 4.3 
x o. 31 3.9 1. 63 2.7 
>. D. + O. 03 +0.05 
- -
TABLE 3 
EFFECT OF VARYING THE MESH SIZE OF THE AG 50W-X4 RESIN* 
Mesh Size of 
AG 50W-X4 Resin 
20-50 
50-100 
100-200 
200-400 
Flow Ratea 
1 min 56 sec 
2 min 42 sec 
6 min 30 sec 
Piggyback 
Flow Rateb 
Flow Rate 
of 1st Washc 
Flow Rate Flow Rate · 
of 2nd Washc of 3rd Washc 
6 min 33 sec 6 min 30 sec 6 min 33 sec 6 min 33 sec 
6 min 9 sec 6 min 27 sec 6 min 8 sec 6 min 3 sec 
7 min 49 sec 7 min 46 sec 7 min 53 sec 7 min 40 sec 
10 min 27 sec 11 min 43 sec 11 min40 sec 11 min 47 sec 11 min 28 sec 
* Each Value represents the mean of two experiments. 
a Time required for 10 ml of water to pass through an AG 50W-X4 column. 
b Time required for 10 ml of water to pass through a piggyback column unit composed of an 
AG 1-XB column on top of an AG 50W-X4 column. The time required for 10 ml of water to 
1 pass through an AG l-X8 column alone was 5 min 47 sec. 
c Time required for 10 ml of water to pass through the piggyback column unit after addition 
of O. 5 ml of an ALA sample to the AG l-X8 column. 
Flow Rate of lM 
Sodium Acetated 
54 sec 
TABLE 3 (Continued) 
EFFECT OF VARYING THE MESH SIZE OF THE AG50Vv-X4 RESIN 
pH of Sodium % Recov;ery of 
Acetate Eluate 10 )lg ALA 
4.69 25 
% Recovery of A LA % Recovery of A LA 
from the Urine of a 
from Normal Urinee Lead-Exposed Indi• 
vi dual 
35 31 
....... 1 min 30 s.ec 4. 57 58 58 61 
~ 
...... 
- 4 min 33 sec 4. 5'7 97 100 100 
7 min 28 sec 4.71 94 97 
d Time required for 7. 0 ml of lM sodium acetate to pass through the AG 50W-X4 column. 
e 100% recovery was arbitrarily set for the amount of ALA eluted from the 100-200 mesh 
AG 50W-X4 column. The ALA eluted from the columns containing 20-50, 50-100, and 
200-400 mesh resin were then compared to this value. 
98 
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TABLE 4 
EFFECT OF URINE pH ON RECOVERY OF ALA FROM COLUMNS 
Optical Density at 553 mµ 
pH 
HCl + NaOH HCl+NH40H HCl +Na2C03 
1. 0 o. 2'50 0.271 o. 241 . 
2.0 0.245 0.289 0~252 
3.0 0.232 0.260 0.256 
4.0 0.249 0.273 0.230 
5.0 0.225 0.260 0.230 
6.0 0.232 0.240 0.228 
7.0 0.210 0.225 0.212 
8. 0 0.188 o. 161 0.200 
9.0 0.127 0.022 0.095 
10. 0 0.085 ----- -----
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I TABLE 5 PERCENTAGE DISTRIBUTION OF URINARY ALA LEVELS IN 250 CHILDREN 
WITH SUSPECTED LEAD INGESTION>:~ l 
I I 
I< Number % Total % Each Range I Urinary A LA Urinary A LA Children in Children in Treated With 
I 
(mg/100 ml) Code Each Range Each Range Chelating Agents 
. ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-
E I Normal range 
I 0. 00-0. 54 0. 55-0.99 Abnormal range Normal Trace 123 64 49.2 4 25.8 5 
1. 00-1. 49 l+ 27 10. 8 65 
i. so-i. 99 2+ 14 5. 6 70 I 
2.00-2.99 3+ 12 4.s 84 I 
3. 00-5. 99 4+ 8 3. 2 100 
6. 00-10. 00 5+ 2 0. 6 100 l 
>!'-All children had an initial blood lead level greater than 40 )lg/100 ml as determined by atomic 
absorption spectrometry. 
t 
I I TABLE 6 
COMPARISON OF URINARY ALA LEVELS WITH THE INCIDENCE OF CHELATION THERAPY IN 
250 CHILDREN WITH SUSPECTED LEAD INGESTIO~>!< 
Urinary ALA 
Level 
Normal >!o!c 
High >!o!o!c 
Chelation 
Therapy 
Not treated 
Treated 
Interpretation 
of ALA Test 
Correct negative 
Correct positive 
Number 
Children 
179 
48 
t-' B Normal >:o:c 
CJ,; Treated False negative 8 
~ 
High >!o:o:c Not treated False positive 15 
>!< All children had an initial blood lead level greater than 40 ;p.g/100 ml as determined by atomic 
absorption spectrometry. 
>:o:c Normal range of urinary ALA = 0. 00 to O. 99 mg/100 ml. 
>!<>:o:c Abnormal range of urinary ALA = 1. 00 to 10. 00 mg/100 ml. 
TABLE 7 
COMPARISON OF VARIOUS LABORATORY TESTS FOR LEAD EXPOSURE IN 250 CHILDREN 
WITH SUSPECTED LEAD INGESTION* IN TERMS OF FREQUENCY OF, ABNORMAL RESULTS 
Children discharg~d without ·Children Treated with 
Chelation Therapy Chelation Therapy 
%with % with % with % with 
Test Normal Test Abnormal Test Normal Test Abnormal Test 
Urinary ALA 92 8 14 86 
Wri~t X-ray 46 54 24 76 
Abdominal X-ray 86 14 57 43 
Hemoglobin 87 . 13 68 32 
Hematocrit 85 15 71 29 
*All children had an initial blood lead level greater than 40 pg/1-00 ml as determined by atomic 
absorption spectrometry. · 
Abnormal urinary ALA = 1.. 00 mg/100 ml or higher 
Abnormal wrist X-ray = increased density at metaphysis 
Abnormal abdominal X-ray = radiopaque material in intestine 
Abnormal hemoglobin = less than 10. 0. g/100 ml 
Abnormal hematocrit = less than 33% 
TABLE 8 
COMPARISON OF.VARIOUS LABORATORY TESTS FOR LEAD EXPOSURE 
IN 250 CHILDREN WITH SUSPECTED LEAD INGESTION* IN TERMS OF 
FREQUENCY OF CHELATION THERAPY. 
Test 
Urinary ALA 
Abdominal X-ray 
Hemoglobin 
Hematocrit 
Wrist X-ray 
Blood Lead 
% of Children with · 
Normal Test Values 
Who Were Discharged. 
without Treatment 
96 
82 
81 
80 
85 
- -
% of Children with 
Abnormal Test Values 
Who Received Chelation 
Therapy 
76 
51 
. 42 
36 
32 
22 
*All children had an initial blood lead level greater than 40 )lg/100 ml 
as determined by atomic absorption spectrometry. 
Abnormal urinary ALA = 1. 00 mg/100 ml or higher 
Abnormal wrist X-ray = increased density at metaphysis 
Abnormal abdominal X-ray = radiopaque material in intestine 
Abnormal hemoglobin = less than 10. 0 g/100 ml 
Abnormal hematocrit = less than 33% 
Abnormal blood lead = greater than 40 pg/100 ml 
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TABLE 9 
COMPARISON OF MEAN URINARY ALA VALUES WITH MEAN BLOOD LEAD VALUES IN 250 
CHILDREN WITH SUSPECTED LEAD INGESTION* CLASSIFIED BY VARIOUS RANGES OF 
URINARY A LA LEVELS 
Urinary ALA 
Code 
Normal A LA Values 
Normal 
Trace 
Abnormal ALA Values 
l+ 
2+ 
3+ 
4+ 
5+ 
Number of 
Children 
123 
64 
27 
14 
12 
8 
2 
Mean Urinary 
ALA+ S. D. 
(mg/100 ml) 
o. 32 + 0. 13 
0. 72 + 0 . .12 
-:-
1.22+0.14 
i. 72 +o. 16 
2. 45 + o. 35 
4. 66 + 0. 79 
8. 69 + 1. 37 
-
Urinary A LA · 
Range 
(mg/100 ml) 
o. oo·-o. 54 
0.55-0.99 
1. 00-1. 49 
1. 50-1. 99 
2.00-2.99 
3.00-4.99 
6. 00-10. 00 
Mean Blood 
Lead + S. D. ** 
· (µg/100 ml) 
48 + 11 
49f. 11 
65 + 17 
68 + 16 
83 + 23 
107 + 46 
147 + 65 
-
* All children had an initial blood lead level greater than 40 )lg/100 ml as determined by atomic 
" · absorption .spectrometry. 
** Represents corresponding blood lead value at time of urinary A LA determination. 
. ,.... 
CA) 
00 
-
Urinary ALA 
Level 
Normal 
High 
TABLE 10 
DISTRIBUTION OF HEMOGLOBIN LEVELS* IN CHILDREN SUSPECTED 
OF LEAD INGESTION** CLASSIFIED BY URINARY ALA LEVELS 
Hemoglobin Levels (g/100 ml) 
Total 6.0- 7.0- . 8. 0- 9.0- 10. 0- 11. 0- 12.0- 13. 0-
Samples 6.9 7. 9 8.9 9.9 10. 9 11. 9 12. 9 13. 9 
166 0 3 5 8 18 29 23 13 
57 4 0 7 11 23 26 . 25 4 
* 
Expressed as percent of total samples. 
14.0-
14. 9 
1 
2 
** All children had an initial blood lead level greater than 40 )lg/100 ml as determined by atomic 
absorption spectrometry. 
Normal range of urinary ALA = 0. 00-0. 99 mg/100 ml 
High range of urinary ALA = L 00-10. 00 mg/100 ml 
f"' 
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TABLE 11 
DISTRIBUTION OF HEMA TOCRIT VALUES* IN CHILDREN SUSPECTED 
OF LEAD INGESTION** CLASSIFIED BY URINARY ALA LEVELS 
Hematocrit Values (%) 
. 
Urinary ALA Total 21.- 24- 27- 30- 33- 36- 39- 42-
:. Level Samples 23 26 29 32 35 38 41 44 
I Normal 180 0 1 2 15 31 32 18 1 
High 61 0 3 5 10 39 30 11 2 
P:< Expressed as percent of total samples. 
** All children had an initial. blood lead level greater than 40 )lg/100 ml as determined by atomic 
absorption spectrometry. 
Normal range of urinary A LA = O. 00-0. 99 mg/100 ml 
:ligh range of urinary ALA = 1. 00-10. 00 mg/100 ml · 
'/ J 
TABLE 12 
PERCENTAGE DISTRIBUTION OF URINARY ALA LEVELS IN 
534 CHILDREN WITH SUSPECTED LEAD INGESTION* 
Number of % of Total 
Urinary ALA Urinary ALA Children in Children in 
(mg/100 ml) Code· Each Range Each Range 
Normal Range 
0.00-0.54 Normal 251 47. 0 
69. 5 
0.55-0.99 Trace 120 22. 5 
Abnormal Range 
1. 00-1. 49 l+ 64 12.0 
1.50-1.99 2+ 26 4. 9 
2.00-2.99 3+ 36 6.7 '30. 5 
3.00-5.99 4+ 27 5.0 
6.00-10.00 5+ 10 1. 9 
* All children had an initial blood lead level greater than 50 pg/100 ml· 
as determined by atomic absorption spectrometry. 
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TABLE 13 
COMPARISON OF ELEVATED URINARY ALA LEVELS WITH THE INCIDENCE OF CHELATION 
THERAPY'IN CHILDR.EN WITH SUSPECTED LEAD INGESTION>:< 
No. in Each % of Each· 
Number of R.ange Treated R.ange Treated 
Urinary ALA Urinary ALA Child:r:en in with Chelating with Chelating 
(mg/100 ml) Code Each Range Agents Agents 
1.00-1.49 1+ 38 26 68.4 
1. 50-1. 99 2+ 23 18 78.3 
2.00-2.99 3+ 32 29 . 90.6 
3.00-5.99 4+ 28 28 100. 0 
6. 00-10. 00 5+ 10 10 100. 0 
-
Total 131 111 84.7 
* 
All children had an initial blood lead level greater than 50 Jlg/100 ml as determined by atomic 
absorption spectrometry.· 
.. 
. 
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TABLE 14 
COMPARISON OF ELEVATED MEAN URINARY ALA VALUES WITH CORRESPONDING MEAN 
BLOOD LEAD VALUES IN 107 CHILDREN WITH SUSPECTED LEAD INGESTION* 
Urinary ALA Urinary A LA Number of Mean Urinary Mean Blood Lead 
Code Range {mg/100 ml) Children A LA (mg/100 ml) Cpg/100 ml) 
1+ 1.00-1.49 31 1. 27 60 
2+ 1. 50-1. 99 20 . 1. 67 74 
3+ 2.00-2.99 30 2~ 41 80 
4+ 3.00-5.99 21 4. 10 95 
5+ 6.00-10.00 5 7.97 127 
* All children had an initial blood lead level greater than 50 )lg/100 ml as determined by atomic 
absorption spectrometry . 
.. -----------------------------------------------------------------------------------.1'<.~· 
TABLE 15 
~ERCENTAGE DISTRIBUTION OF URINARY ALA LEVEL_8 IN 4, 189 AP-
PARENTLY-WELL, ASYMPTOMATIC CHILDREN RESIDING IN HIGH-
INCIDENCE AREAS OF LEAD POISONING IN.THE CITY OF CHICAGO 
·- Number of 
Children % of Total 
Urinary ALA Urinary ALA in Each in each 
(mg/100 ml) Code Category Category 
Normal range 
0.00-0.54 Normal 3251 77. 61 
94.11 
0.55-0.99 Trace 691 16.50 
- -
Abnormal range 
1. 00-1. 49 1+ 212 5.06 
1.50-1.99 2+ 20 0.48 
5.90 
2.00-2.99 3+ 13 0.31 
3.00-5.99 4+ 2 0.05 
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TABLE 16 
DISTRIBUTION OF THE URINARY ALA LEVELS* OF 4, 189 ASYMPTOMATIC CHILDREN 
CLASSIFIED BY THE LOCATION OF THE URBAN PROGRESS CENTERS 
WHERE THEY WERE EXAMINED 
Number of Chil- Urinary ALA Levels (mg/100 ml) 
dren Examined 
at Each UPC o. 00-0. 54 0. 55-0. 99 1. 00-1. 49 1. 50-1. 99 2. 00-2. 99 3. 00-5. 99 
South Parkway UPC 872 74.4 ' 18.0 6. 7 o. 6 0.2 o. 1 
Woodlawn UPC 427 71. 4 19.7 7.5 0.9 0.5 0.0 
Englewood UPC 588 79. 1 15.3 4. 4 0.5 o. 5 0.2 
South Chicago Unit 121 76.0 17.4 6. 6 o. 0 0.0 0.0 
Division St. Unit 258 82.2 15. 5 2.3 0.0 o. 0 o.o 
Montrose UPC 259 78.8 18. 1 2.3 0.8 o. 0 0.0 
Halsted UPC 857 82.0 13.8 3.7 0.1 0.4 o.o 
Lawndale UPC 595 . 78. 5 15. 8 4. 9 0.7 0.2 0.0 
~ 
Midwest UPC 212 72.6 18. 9 7. 1 . o. 5 i. 0 o.o 
-
~c Expressed as percent of children examined at each UPC. 
" 
TABLE 17 
DISTRIBUTION OF CHILDREN HAVING ELEVATED URINARY 
ALA LEVELS* BY AGE 
Number of Children in Each 
Age (years) Age Group Having o/o of Total 
Elevated Urinary ALA Levels 
1 4 1. 8 
2 I 32 14.1 
3 35 15.4 
4 39 17~2 
5 31 13.7 
6 32 14. 1 
7 22 - 9. 7 
8 11 4.8 
9 11 4. 8 
10 10 4.4 
-- --.. 
Total 227** 100.0 
* Elevated Urinary ALA Levels = 1. 00 mg/100 ml or higher. 
** In this table the number of children reported to have had elevated ~rinary 
ALA levels is less than the actual number found durLng the course of the 
epidemiological field study. This difference occurs because in several 
instances the age of the child having an elevated urinary ALA level was 
not indicated on the physician's report form and therefore these 
children could not be included in the table. 
-
pi::., 
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TABLE 18 
DISTRIBUTION OF THE URINARY ALA LEVELS* OF 3, 919** ASYMPTOMATIC 
CHILDREN CLASSIFIED BY AGE 
Number of Children in Each UR.INARY ALA LEVELS (mg/100 ml) 
Age Age Group Tested for Urin-
(years) ary A LA Excretion 0.00-0.99 1.00-1.49 1. 50-1.99 2.00-2.99 3·. 00-5. 99 
1 103 96. 1 3.9 o.o o.o o.o 
; 
2 459 : 93. 1 5. 4 o.~ 0.4 0.2 
3 6.66 94.7 4. 8 0.5 o.o o.o 
4 704 ; 94.5 4.4 0.7 0.3 o. 1 
' 
5 655 95~2 4. 1 0.5 0.2 o.o 
6 502 93.6 6.0 0.2 0.2 o.o 
7 353 93.7 5. 4 0.6 o. 3 o.o 
' 
8 206 94,7 5. 3 o.o o.o o.o 
9 145 92.4 6. 2 o.o 1. 4 o.o 
i 
.. 
·10 126 92.1 5. 6. 0.8 1. 5 o.o 
*Expressed as % of children in each age group tested for urinary ALA excretion.· 
**In this table the number of asymptomatic children reported to have been tested for urinary ALA 
. excretion is less than the actual number tested during the. course of the epidemiological field study. 
This difference occurs because in several instances the age of the child tested was not indicated on 
the physician's report form and therefore these children could not be included in the table. 
Race 
White 
Negro 
Other 
Total 
TABLE 19 
DISTRIBUTION OF CHILDREN HAVING ELEVATED URINARY 
ALA LEVELS':c ACCORDING TO RACE 
Number of Children of Each 
Race Having Elevated Urin- % of Total 
ary A LA Levels 
22 10.3 
190 88.8 
2 0.9 
2 l 4::1c:>;c 100.0 
* Elevated Urinary ALA Levels = 1.00 mg/100 ml or higher. 
** ·In this table the number of children reported to have had elevated 
urinary ALA levels is less than the actual number found during the 
course of the epidemiological field study. This difference occurs 
because in several instances the race of the child having an elevated 
urinary ALA level was not indicated on the physician's report form and 
therefore these children could not be included in the table. 
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Race 
White 
~egro 
lather 
TABLE 20 
DISTRIBUTION OF THE URINARY ALA LEVELS* OF 3, 606** ASYMPTOMATIC 
CHILDREN CLASSIFIED BY RACE 
Number of Children of URINARY ALA LEVELS (mg/100 ml) 
Each Race Tested for 
Urinary ALA Excretion o. oo-o. 99 ·i. 00-1. 49 1. 50-1. 99 2. 00-2. 99 3. 00-5. 99 
879 97.5 2. 2 0.2 o. 1 o.o 
2, 697 93.0 6.0 o. 6 0.3 0.07 
30 93.3 6.7 o.o o.o o.o 
* Expressed as % of children of each race tested for urinary ALA excretion. 
** In this table the number of asymptomatic children reported to have been tested for urinary ALA 
excretion is less than the actual number tested during the course of the epidemiological field study. 
This difference occurs because in several instances the race of the .child tested was not indicated 
on the physician's report form and therefore these children could not be included in the table. 
:i 
Sex 
Male 
Female 
Total 
TABLE 21 
DISTRIBUTION OF CHILDREN HAVING ELEVA TED URINARY 
ALA LEVELS>:< ACCORDING TO SEX 
Number of Children of Each 
Sex Having % of Total 
Elevated Urinary A LA Levels 
146 62.7 
87 37.3 
233>:0 !<: 100. 0 
* Elevated Urinary ALA levels = 1. 00 mg/100 ml or higher. 
** In this table the number of children reported.to have haa elevated urinary. 
ALA levels is less than the actual number found during the course ·of the 
epidemiological field study. This difference occurs because in s~everal 
. instances the sex of the child having an elevated urinary ALA level.·~ 
was not indicated on the physician's report form and therefore these 
children could not be included in the table. 
149 
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~ IFemale 
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TABLE 22 
DISTRIBUTION OF THE URINARY ALA LEVELS* OF 4, 019** ASYMPTOMATIC 
CHILDREN CLASSIFIED BY SEX 
URINARY ALA LEVELS (mg/100 ml) Number of Children of 
Each Sex Tested for 
Urinary ALA Excretion o. 00-0. 99 1. 00-1. 49 1. 50-1. 99 2. 00-2. 99 3. 00-5. 99 
2,126 93.1 6. 1 0.5 0.2 o. 1 
1. 893 95.4 3. 8 0.5 0.3 o.o 
* Expressed as % of children of each sex tested for urinary ALA excretion. 
** In. this table the number of asymptomatic child.ren reported to have bee.n tested for urinary A LA 
excretion is less than the actual number tested during the course of the epidemiological field study. 
This difference occur.s because in several instances the sex of the child tested was not indicated 
on the physician's report form and therefore these children could not be included in the table. 
... 
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TABLE 23 
DISTRIBUTION OF BLOOD LEAD VALUES IN 3, 068 CHILDREN WITH NOR.MAL 
LEVELS OF URINARY ALA {O. 00-0. 99 mg/100 ml) 
Blood Lead Levels (Jlg/100 ml} 
0-9 10-19 20-29 30-39 40-49 50-59 60-64 65-69 70-79 80-89 90-99 100-129 130-300 
IN o. of children 
~n each blood 
ead range 7 481 1246 868 334 95 15 11 6 3 1 1 0 
1% of children 
in each blood 
lead range o. 2 15. 7 40.6 28.3 10. 9 3.1 0.5 0.4 0.2 0.1 0.03 0.03 0.0 
! 
TABLE 24 
DISTRIBUTION OF URINARY ALA VALUES IN 3, 148 CHILDREN WITH NORMAL 
LEVELS OF BLOOD LEAD (0-59 pg/100 ml) 
URINARY ALA LEVELS (mg/100 ml) 
Normal 'l+ 2+ 3+ 4+ 5+ 
(O. 00-0. 99) (1. 00-1. 49) (1. 50-1. 99) (2. 00-2. 99) (3. 00-5'. 99) (6. 00-10. 00) 
Number of children in 
each urinary ALA range 2,982 152 12 1 1 0 
~ l % ~f children in each 
urinary A LA range 947 4.8 0.4 0.03 0.03 o.o 
TABLE 25 
EFFECT OF VARIOUS METALS ON URINARY ALA EXCRETION IN RATS 
URINARY ALA ()lg/24 HOURS)a 
·nose 
Compound {mg/kg) Day 0 Day 1 Day 2 Dal 3 Day 4 Dal 5 ·Day 14 
Controlb 33+25 37+9 39+20 39+17 34+17 35+18 24+7 
- -
Le~d acetate 50 27+11 29l+U3 366+141 346+109 185+228 201+152 246+266 
- - - - -
Tetraethyl lead 10 37+5 32+1 39+3 22-+:2 16+6 27+16 44+24 
-
Cadmium chloride 4.5 37+4 23+8 32+8 20+6 24+4 22+3 27+4 
- - - - -
Barium chloride 15 34+11 35+4 30+27 28+11 36+22 31+17 37+15 
- - - - -
Ferrous sulfate 100 47+21 35+6 32+15 75+33 47+16 51+12 35+9 
-
Zinc chloride 19 33+19 33+4 36+20 26+21 33+11 33+18 38+15 
a . Data are expressed as mean of 3 animals·~ standard deviation. 
b Each metal with the exception of tetraethyl lead was dissolved in distilled water. A single intra-
peritoneal injection of 1 ml was used to administer the desired quantity of each metal and a 1 ml 
irrtraperitoneal injection of distilled water was used as control. Tetraethyl lead was diluted to the 
desired strength with pean~t oil and 1 nil of this solution was acbninistered orally. 
TABLE 25 (Continued) 
EFFECT OF VARIOUS METALS ON URINARY ALA__EXCRETION IN RATS 
URINARY ALA (,µg/24 HOURS)a 
Dose 
Compound (mg/kg) Day 0 Day 1 Day 2 Day 3 Day 4 Day 5 Day 14 
Strontium bromide 500 48+26 42+12 61+10 47+34 46+32 50+27 54+30 
- - - -
- - -
Copper sulfate 15 33+14 29+21 25+18 28+19 25+13 24+14 34+16 
- - - - - - -
Arsenic pentoxide 2 40+13 52+22 38+12 49+38 40+20 30+11 25+8 
-
- - -
-
- -
Titanium dioxide 500 40+26 34+4 31+16 31+18 50+6 35+19 35+20 
t--1 
tn 
H:>- I 16c 3d Mercuric chloride 2 37+6 13+8 4+4 1+0.4 e 
Lithium chloride 250 37+19 20+9 35+2 33+10 22+5 54+17 35+22 
c On Day 2 anuria occurred in 2 animals. 
d On Day 5 two animals died. 
e By Day 14 all animals had died. 
TABLE 26 
URINARY ALA CONVERSION CHART FOR AO. 5ml ALIQUOT OF URINE 
pg ALA per )lgALA per )lg A LA per 
14. 2ml Final 14. 2ml Final 14. 2ml Final 
O. D. Reaction Vol. mg% O. D. Reaction Vol. mg% 0. D. Reaction Vol. mg~ 
o. 010 = 0.15 = 0.03 0. 360 = 9.25 = 1.85 0. 710 = 18.60 = 3. 72 
0.0~0 = 0.40 = 0.08 0. 370 = 9.50 = 1. 90 o. 720 = 18. 85 = 3. 77 
0. 030 = 0.65 = 0.13 0. 380 = 9.75 = 1. 95 0. 730 = 19.10 = 3. 82 
o. 040 = 1. 00 = 0.20 0. 390 = 10. oo = 2.00 0. 740 = 19. 50 = 3. 90 
0. 050 = 1. 25 = 0.25 o. 400 = 10. 25 = 2.05 0. 750 ;:: . 19. 75 = 3. 95 
o. 060 = 1.50 = 0.30 0. 410 = 10. 50 = 2.10 0. 760 = 20. 00 = 4. 00 
o. 070 = 1. 75 = 0.35 o. 420 = 10. 75 = 2.15 0. 770 = 20.25=4.05 
0. 080 = 2.00 = 0.40 o. 430 = 11.10 = 2.22 o. 780 = 20. 60 = 4.12 
0. 090 = 2.25 = 0.45 0. 440 = 11. 35 = 2.27 0. 790 = 21. 00 =4. 20 
0.100 = 2.50 = 0.50 o. 450 = 11. 60 = 2.32 o. 800 = 21.25 =4.25 
0.110 = 2.75 = 0.55 0. 460 = 11. .85 = 2.37 0. 810 = 21. 50 =4. 30 
0.120 = 3.00 = 0.60 o. 470 = 12.10 = 2.42 0. 820 = 21. 85 = 4. 37 
0.130 = 3.25 = 0.65 o. 480 = 12. 35 ·= 2.47 0. 830 = 22. 25 =4. 45 
0.140 = 3.50 = 0.70 0. 490 = 12. 60 = 2.52 0. 840 = 22. 60 =4. 52 
0.150 = 3. 75 = 0.75 o. 500 = 13. 00 = 2.60 o. 850 = 23. 00 =4. 60 
0.160 = 4.00 = 0.80 0. 510 = 13. 25 = 2.65 0. 860 = 23. 35 = 4. 67 
0.170 = 4.25 = 0.85 0. 520 = 13. 50 = 2.70 0. 870 = 23. 60 = 4. 72 
0.180 = 4.50 = 0.90 o. 530 = 13. 75 = 2.75 0. 880 = 24. 00 = 4. 80 
0.190 = 4.75 = 0.95 o. 540 = 14.10 = 2. 82 o. 890 = 24. 35 = 4. 87 
0. 200 = 5.00 = I. 00 o. 550 = 14. 35 = 2.87 0. 900 = 24. 75 =4. 95 
0. 210 = 5.35 = I. 07 0. 560 = 14. 60 = 2.92 0. 910 = 25.10 = 5. 02 
0. 220 :: 5.60 = L 12 0. 570 = 14. 85 = 2.97 0. 920 = 25. 35 = 5. 07 
o. 230 = 5.85 = 1. 17 0. 580 = 15.10 = 3.02 0. 930 = 25.75=5.15 
0. 240 = 6.10 = 1. 22 o. 590 = 15. 35 = 3.07 o~ 940 = 26. 25 = 5. 25 
o. 250 = 6. 35 = I. 27 o. 600 = 15. 60 = 3.12 0. 950 = 26. 60 = 5. 32 
o. 260 = 6.60 = 1. 32 o. 610 = 15. 85 = 3.17 ~. 960 ~ 27. 00 = 5. 40 
o. 270 = 6.85 = I. 37 0. 620 = 16. 25 = 3.25 0. 970 = 27.35=5.47 
0. 280 = 7.10 = l. 42 0. 630 = 16. 50 = 3.30 0. 980 = 27. 75 = 5. 55 
0. 290 = 7.35 = 1. 47 0. 640 = 16. 75 = 3.35 0. 990 = 28. 10 = 5. 62 
0. 300 = 7.60 = I. 52 0. 650 = 17. 00 = 3.40 ~.000 = 28. 50 = 5. 70 
o. 310 = 7.85 = 1. 57 0. 660 = 17. 25 = 3.45 ti.. 100 = 32. 50 = 6. 50 
0. 320 = 8.10 = 1. 62 0. 670 = 17. 50 = 3.50 ~. 200 = 37. 00 = 7. 40 
o. 330 = 8.50 = 1. 70 o. 680 = 17. 75 = 3. 55 t 300 = 41. 60 = 8. 32 
o. 340 = 8.75 = 1. 75 0. 690 = 18.10 = 3. 62 L400 = 46.25=9.25 
0. 350 = 9.00 = 1. 80 o. 700 = 18. 35 = 3. 67 
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TABLE 27 
CLASSIFICATION OF URINARY ALA LEVELS IN TERMS OF THEIR 
RELATIONSHIP TO LEAD EXPOSURE IN CHILDREN 
Urinary A LA Range 
(mg/100 ml) 
o. 00 - 0. 99 
1. 00 - 1. 49 
1. 50 - 1. 99 
2. 00 - 2. 99 
3. 00 - 5. 99 
6. 00 - 10. 00 
Urinary ALA Code 
Normal 
1+ 
2+ 
3+ 
4+ 
5+ 
* Terms employed were arbitrarily selected. 
156 
Relationship to 
Lead Exposure* 
None 
Moderate 
Heavy 
Severe 
Critical 
Overwhelming 
• 
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